Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1050.Time spend outdoors in summer,44945,0.0318567108023764,0.05012025764515,-0.0663789941821176,0.13009241578687,0.52504068952779
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1060.Time spent outdoors in winter,41824,0.0363636661921598,0.0573794053400736,-0.0760999682743845,0.148827300658704,0.526258383826214
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1070.Time spent watching television (TV),46255,-0.0315583448093649,0.0505444422938446,-0.1306254517053,0.0675087620865706,0.532392306869873
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1080.Time spent using computer,41842,0.0130825666023708,0.0542941364927875,-0.0933339409234928,0.119499074128234,0.809591079611918
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X1090.Time spent driving,39616,-0.0613358457777829,0.0589556428844659,-0.176888905831336,0.0542172142757702,0.298183333551861
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1160.Sleep duration,47529,0.055199024636907,0.0464343661024449,-0.035812332923885,0.146210382197699,0.234548834180941
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32357,0.00543629140533778,0.0100116747032786,-0.0141865910130883,0.0250591738237639,0.587148410013587
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32357,-0.00707917215151283,0.00895642642945488,-0.0246337679532444,0.0104754236502187,0.429317084583371
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32357,0.00618367439310012,0.0105249553312909,-0.01444523805623,0.0268125868424302,0.556867945605826
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32357,-0.000190242248801261,0.0106796914044754,-0.0211224374015731,0.0207419529039705,0.985788117009026
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32357,0.00497480861477137,0.0108656607803073,-0.0163218865146309,0.0262715037441737,0.647075054731552
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32357,-0.0302171358246394,0.0209343915306198,-0.0712485432246541,0.0108142715753754,0.148941598802211
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32357,-0.0132368987309152,0.0205754335198212,-0.0535647484297647,0.0270909509679342,0.52002534216422
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32357,0.000279850668689348,0.0161482184106524,-0.0313706574161894,0.0319303587535681,0.986173689053369
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32357,-0.00633484080091726,0.0116214319509088,-0.0291128474246985,0.016443165822864,0.585700224885803
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32357,-0.00724020663870054,0.00800665473320615,-0.0229332499157846,0.00845283663838352,0.365877889305556
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32357,-0.00435081343250386,0.011102191816457,-0.0261111093927596,0.0174094825277519,0.695151687927277
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32357,-0.0152834949219461,0.00681177537282304,-0.0286345746526793,-0.00193241519121297,0.024880090493195
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32357,-0.0087474020290635,0.00848562703359993,-0.0253792310149194,0.00788442695679237,0.302643069499181
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32357,-0.0101873105389685,0.012100984596699,-0.0339052403484986,0.0135306192705616,0.399892916155795
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32357,-0.0139810989179014,0.0114393691028284,-0.0364022623594451,0.00844006452364218,0.221671683899521
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32357,-0.00642334920004743,0.0159282084729629,-0.0376426378070547,0.0247959394069598,0.686761412785346
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32357,-0.0172943948781654,0.015137379482264,-0.0469636586634029,0.0123748689070721,0.253282527249805
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32357,0.0104440313778207,0.00901400748392484,-0.00722342329067194,0.0281114860463134,0.246636069054156
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32357,0.00395141724476777,0.00840356033052169,-0.0125195610030547,0.0204223954925903,0.638219735234377
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32357,0.00675941536594838,0.0111660782493093,-0.0151260980026978,0.0286449287345946,0.544962064937445
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120040.Fatigue severity over the past week,32363,-0.074922578115844,0.0806115461503739,-0.232921208570577,0.0830760523388887,0.352696009326971
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120041.Waking unrefreshed severity over the past week,32361,-0.0945920803653032,0.0806174054164068,-0.25260219498146,0.0634180342508541,0.240692574006979
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120042.Cognitive symptoms severity over the past week,32360,-0.0807893858330626,0.0852527352963044,-0.247884747013819,0.086305975347694,0.343338829520047
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120098.Mobility problems today,32366,0.0442839145143295,0.0931763069559426,-0.138341647119318,0.226909476147977,0.634607575575638
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120099.Self-care problems today,32366,-0.0580999156445513,0.150294038950452,-0.352676231987437,0.236476400698334,0.699081278037031
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120100.Problems doing usual activities,32366,0.107137666567382,0.0890051746013068,-0.0673124756511792,0.281587808785943,0.228732281930252
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120101.Pain or discomfort today,32366,-0.07527173815034,0.0804884500306158,-0.233029100210347,0.082485623909667,0.349720571011986
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120102.Anxiety or depression today,32366,-0.0528672134229025,0.0945381907625302,-0.238162067317462,0.132427640471657,0.576030545328549
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120103.Scale to indicate how health is today,32332,-0.000413416639975301,0.00292613913334304,-0.00614864934132765,0.00532181606137705,0.887649200846589
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32342,-0.0941080368113504,0.0974605756698606,-0.285130765124277,0.0969146915015764,0.334273438667378
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32320,-0.10962935667653,0.0989248129835324,-0.303521990124253,0.0842632767711934,0.267805498131214
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32350,0.0103966252380402,0.0803139470296676,-0.147018710940108,0.167811961416189,0.897005033187415
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32348,-0.113260643619419,0.0828536321887051,-0.275653762709281,0.0491324754704426,0.171665258962024
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32352,0.10537361499539,0.0992226874334029,-0.0891028523740793,0.29985008236486,0.288272178611213
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120109.Feeling bad about self over the last two weeks,32327,-0.00969026860960532,0.102784929317978,-0.211148730072842,0.191768192853631,0.924891412120845
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120110.Trouble concentrating over the last two weeks,32349,-0.0593068476411042,0.105822517397342,-0.266718981739895,0.148105286457687,0.575197344868229
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32340,-0.236638682108875,0.158892138705033,-0.548067273970739,0.0747899097529893,0.13644735035843
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32307,-0.223667329006522,0.216490674325455,-0.647989050684414,0.20065439267137,0.301565546920017
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30388,0.0883240502895153,0.10440117015897,-0.116302243222066,0.292950343801097,0.397583328848055
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45526,0.0701887440753046,0.110068790762274,-0.145546085818753,0.285923573969362,0.523688476760902
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43956,-0.11375308358844,0.0735067194762657,-0.25782625376192,0.0303200865850411,0.121754245627163
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1289.Cooked vegetable intake,47072,-0.0368833516935468,0.0484931902969991,-0.131930004675665,0.0581633012885714,0.446910956654408
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46660,0.0216626999565904,0.0524978176623918,-0.0812330226616974,0.124558422574878,0.679874367239309
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1309.Fresh fruit intake,47120,0.0396688528276821,0.0501296970694918,-0.0585853534285217,0.137923059083886,0.428762989142292
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1319.Dried fruit intake,45676,0.0770011302479979,0.0505491661778807,-0.0220752354606482,0.176077495956644,0.127700617730972
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X134.Number of self-reported cancers,47777,0.0711203319481606,0.0824946946561269,-0.0905692695778481,0.232809933474169,0.388630312319411
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X135.Number of self-reported non-cancer illnesses,47777,0.0176055037445876,0.0479548392579216,-0.0763859812009388,0.111596988690114,0.713527813823887
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X136.Number of operations, self-reported",47777,-0.0588016325157299,0.0484635923065027,-0.153790273436475,0.0361870084050155,0.225021468371865
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X137.Number of treatments or medications taken,47777,-0.0246831353442493,0.0469370901732613,-0.116679832083841,0.0673135613953428,0.598978682205999
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1438.Bread intake,46968,-4.09035884518447e-05,0.00191041531792697,-0.00378531761158871,0.00370351043468502,0.982918119648322
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1458.Cereal intake,46591,-0.0169621496245921,0.0477544926284782,-0.110560955176409,0.0766366559272253,0.722447009946619
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1488.Tea intake,46983,-0.00120676219996989,0.0017738446694435,-0.00468349775207915,0.00226997335213936,0.496315921958357
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1498.Coffee intake,45933,0.0279625787172563,0.0481594004537897,-0.0664298461721715,0.122355003606684,0.561498934968725
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X1528.Water intake,46320,0.00698397720733265,0.049382987423306,-0.0898066781423471,0.103774632557012,0.887535696969558
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1568.Average weekly red wine intake,38685,0.0319783723796155,0.0602311679536004,-0.0860747168094413,0.150031461568672,0.595477432172743
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38680,0.0915499114609193,0.0606996264283232,-0.0274213563385942,0.210521179260433,0.131514024666897
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1588.Average weekly beer plus cider intake,38709,-0.153053148980434,0.0770565218952927,-0.304083931895207,-0.00202236606565984,0.047025218305912
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1598.Average weekly spirits intake,38645,0.00247344317707352,0.0676009616895224,-0.13002444173439,0.134971328088537,0.970813328187524
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1608.Average weekly fortified wine intake,38709,-0.00863627290358182,0.104271141123821,-0.213007709506271,0.195735163699107,0.933991733868698
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X1737.Childhood sunburn occasions,42212,-0.0713394724980495,0.0569234216356329,-0.18290937890389,0.0402304339077909,0.210129996251788
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1807.Father's age at death,41552,0.000561205321412828,0.00200332930937153,-0.00336532012495537,0.00448773076778102,0.779376301042687
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1845.Mother's age,33516,-0.000755140891820799,0.00476594404192036,-0.0100963912139847,0.00858610943034312,0.874109539695531
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1873.Number of full brothers,47345,-0.0254031084969649,0.0465857525635243,-0.116711183521473,0.0659049665275427,0.5855540279915
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X1883.Number of full sisters,47347,0.052194850077013,0.0466657525409708,-0.0392700249032897,0.143659725057316,0.263372506279074
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20015.Sitting height,47614,0.00376500323396033,0.00234353766737347,-0.00082833059409168,0.00835833706201233,0.108167424735745
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20016.Fluid intelligence score,32010,0.0205556599358257,0.0752539899617461,-0.126942160389197,0.168053480260848,0.784745055264163
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20018.Prospective memory result,32299,-0.0410530853626991,0.0983626810429653,-0.233843940206911,0.151737769481513,0.676423279975921
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31906,0.00629019271950129,0.00328520504820659,-0.000148809174983628,0.0127291946139862,0.0555685980906777
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31891,0.0038960368508866,0.0032847090819435,-0.00254199294972266,0.0103340666514958,0.235615474087992
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20023.Mean time to correctly identify matches,47505,0.000122211913344383,0.0019196461155159,-0.00364029447306677,0.00388471829975554,0.949238503631707
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#1.Illnesses of father_Heart disease,45067,-0.000678871267110062,0.00394736522100805,-0.00841570710028584,0.00705796456606572,0.863454264115915
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44707,-0.00988325750620628,0.00856750427086598,-0.0266755658771036,0.00690905086469103,0.248688123556354
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44677,-0.00990066940739311,0.0118451012133363,-0.0331170677855322,0.013315728970746,0.403251944154946
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#12.Illnesses of father_Severe depression,44696,0.0088050385845913,0.00930322591808717,-0.00942928421485956,0.0270393613840422,0.343930387125581
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44701,0.0123919888637534,0.00703136943809694,-0.00138949523491657,0.0261734729624234,0.07801914378351
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#2.Illnesses of father_Stroke,44834,0.000981096612157756,0.005151464230459,-0.00911577327954188,0.0110779665038574,0.848958379042951
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44782,0.00611259389319488,0.00646731423554764,-0.0065633420084785,0.0187885297948683,0.344592599626726
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44702,-0.0122060626596105,0.00821947666927806,-0.0283162369313955,0.00390411161217447,0.137554884494542
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44839,-0.00372700452433563,0.00581571701177648,-0.0151258098674175,0.00767180081874627,0.521627092735835
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44884,0.00362029557669405,0.00440704213582951,-0.0050175070095318,0.0122580981629199,0.411382677164688
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20107#9.Illnesses of father_Diabetes,44770,0.00167284269160428,0.00616077260972279,-0.0104022716234524,0.013747957006661,0.785985176409791
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46218,-0.00147943305257492,0.00438260158605844,-0.0100693321612495,0.00711046605609963,0.735690811657084
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46109,-0.00063712703207937,0.00641785113550089,-0.0132161152576611,0.0119418611935024,0.92092148208677
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46052,0.00738369984310022,0.0138372126673274,-0.0197372369848615,0.0345046366710619,0.593615639111387
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46080,0.00351483257647705,0.00688227669524302,-0.00997442974619927,0.0170040948991534,0.609560871717236
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#2.Illnesses of mother_Stroke,46165,0.00502325614817031,0.0050230418820009,-0.00482190594055145,0.0148684182368921,0.317301009374818
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46065,0.00473059742142967,0.00932134009910883,-0.0135392291728236,0.023000424015683,0.61180791134178
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46063,-0.000909751073837014,0.00824805551621908,-0.0170759398856264,0.0152564377379524,0.912173390035913
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46087,-0.00773761288695577,0.00655057512475625,-0.020576740131478,0.00510151435756648,0.237531806362375
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46108,-0.00714215776993556,0.00734960883771124,-0.0215473910918496,0.00726307555197847,0.331173915138927
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46249,0.00553477622438832,0.0038061756652903,-0.00192532807958066,0.0129948805283573,0.145917237466493
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46122,-0.00375446703796249,0.00598911200805445,-0.0154931265737492,0.00798419249782424,0.530743133841802
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43213,-0.00830712010993596,0.00618702834408053,-0.0204336956643338,0.00381945544446187,0.179396000040372
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43085,-0.0075574350054558,0.0244910971393369,-0.0555599853985561,0.0404451153876445,0.757645348293347
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43083,-0.00226492670577251,0.0253389386644616,-0.0519292464881173,0.0473993930765723,0.928776726876035
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43137,-0.00114305883005836,0.00694028468031884,-0.0147460168034833,0.0124598991433666,0.869182585508551
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43096,0.0263496358770402,0.0147304717030054,-0.00252208866085047,0.0552213604149308,0.0736657968938753
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43110,0.00487971381990764,0.0104348290918682,-0.0155725512001541,0.0253319788399694,0.640049549432178
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43091,0.00807391352791013,0.0128269285924652,-0.0170668665133216,0.0332146935691418,0.529062038045097
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43089,-7.53024483899937e-06,0.0125938550886494,-0.0246914862185918,0.0246764257289138,0.999522927245043
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43104,-0.00129586140188453,0.009071003902588,-0.019075029050957,0.0164833062471879,0.886404227199031
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43112,-0.0178522366822263,0.0111286118202645,-0.0396643158499448,0.00395984248549225,0.108692490220099
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43263,-0.00619173005083189,0.00457271626862796,-0.0151542539373427,0.0027707938356789,0.175733651751671
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43166,-0.0116605198125974,0.00656006228626514,-0.024518241893677,0.00119720226848231,0.075502019167172
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20127.Neuroticism score,42773,0.024840818203184,0.0481812881675325,-0.0695945066051797,0.119276143011548,0.606161116290213
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32010,0.0313529381374684,0.0753687470772789,-0.116369806133998,0.179075682408935,0.677426303932445
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20161.Pack years of smoking,30697,-0.000674072818748453,0.00386050712841297,-0.00824066679043787,0.00689252115294096,0.861393852514266
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30697,-0.000622622754129381,0.00380630287434119,-0.00808297638783811,0.00683773087957935,0.870069620529869
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20191.Fluid intelligence score,30256,-0.0184946526452647,0.0868149897090721,-0.188652032475046,0.151662727184517,0.831306969158058
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30256,-0.00222354450686671,0.0878002052669981,-0.174311946830183,0.16986485781645,0.979796566498728
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X20240.Maximum digits remembered correctly,29616,-0.144197582307459,0.0946069346937954,-0.329627174307298,0.0412320096923796,0.127526179427167
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X20255.Spirometry QC measure,42331,-0.103139930961632,0.0648211552713545,-0.230189395293487,0.0239095333702233,0.111594368468764
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20261.avMSE,29587,-0.00555583811420642,0.00374191443389859,-0.0128899904046477,0.00177831417623481,0.137669271508235
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X20262.Myopia diagnosis,29587,0.150089933355623,0.112811532219342,-0.0710206697942885,0.371200536505534,0.183429636571853
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20280.Glucose-lactate,37448,-0.00149226583860917,0.00245909628583882,-0.00631209455885326,0.00332756288163492,0.543970980055065
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X20281.Spectrometer-corrected alanine,37476,-0.00239600440019845,0.00234668909293566,-0.00699551502235236,0.00220350622195545,0.307266370236321
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31792,0.00183958484715472,0.0112728239358861,-0.0202551500671821,0.0239343197614915,0.870375238168047
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31790,-0.011645898400428,0.0212674954175114,-0.0533301894187502,0.0300383926178943,0.583989124188411
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31788,0.0464701970810536,0.0269574148577231,-0.00636633604008367,0.0993067302021908,0.0847793513509407
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31788,0.00305105545819766,0.010593947261438,-0.0177130811742208,0.0238151920906161,0.773354972232452
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31788,-0.011906862235263,0.0208453432932076,-0.0527637350899498,0.0289500106194238,0.567881506204222
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31794,-0.0106841969723047,0.0252707081363349,-0.0602147849195212,0.0388463909749118,0.672461031430277
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31794,0.0141497224999044,0.0170195838468383,-0.0192086618398986,0.0475081068397074,0.405786664934136
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31794,0.0154079545943281,0.0187403862863502,-0.0213232025269183,0.0521391117155744,0.411001651109313
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31794,0.011327229807286,0.0302567767033136,-0.0479760525312088,0.0706305121457807,0.708139863244665
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31794,0.0169326329932524,0.0365432312328028,-0.0546921002230412,0.0885573662095459,0.643120837513422
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31794,0.00771904209611957,0.0195392406895868,-0.0305778696554706,0.0460159538477097,0.692815007120408
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31794,0.00943272281027775,0.0372421477244826,-0.0635618867297082,0.0824273323502637,0.800058285100838
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31794,0.0410160595752162,0.0254788470746481,-0.00892248069109408,0.0909545998415265,0.107482702548458
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31794,0.0661072057324059,0.0312536194647348,0.0048501115815258,0.127364299883286,0.0344477249371037
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31794,0.0078988743601501,0.0143046316997971,-0.0201382037714522,0.0359359524917524,0.580835003381001
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31794,-0.0181880550146929,0.0234671032508006,-0.0641835773862621,0.0278074673568762,0.438338181404673
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31795,0.00947499035838619,0.0356274392392087,-0.0603547905504629,0.0793047712672353,0.790287930930791
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20600.Liking for adding salt to foods,33122,-0.0930641134879349,0.0717212264859805,-0.233637717400457,0.0475094904245869,0.194465852243887
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20601.Liking for aniseed,33122,-0.0958403164193049,0.0716314667783266,-0.236237991304825,0.0445573584662153,0.18094333341701
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20602.Liking for apple juice,33122,0.0887227725491301,0.0713188572203131,-0.0510621876026837,0.228507732700944,0.213522319845668
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20603.Liking for apples,33122,0.0987098224773022,0.0735866675164551,-0.0455200458549498,0.242939690809554,0.179822849332165
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20604.Liking for asparagus,33122,-0.0307068195619446,0.0743931641313915,-0.176517421259472,0.115103782135583,0.67978975110598
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20605.Liking for aubergine,33122,-0.0211454162822533,0.0735061042054827,-0.165217380525,0.122926547960493,0.773607121211728
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20606.Liking for avocados,33122,0.00360217280848362,0.074362342059753,-0.142148017628632,0.149352363245599,0.961366044938783
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20607.Liking for bacon,33122,-0.0504677059771845,0.0722793695377656,-0.192135270271205,0.091199858316836,0.485051406036783
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20608.Liking for baked or steamed fish,33122,0.0511008134346318,0.0743351886037953,-0.094596156228807,0.196797783098071,0.491825334870037
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20609.Liking for bananas,33122,0.0251966675452808,0.0751289327004001,-0.122056040547503,0.172449375638065,0.737347317709299
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33122,-0.0841071412817568,0.0724380298687971,-0.226085679824599,0.0578713972610856,0.245636912233171
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20611.Liking for beef steak,33122,-0.115630145422655,0.0721967647409929,-0.257135804315002,0.0258755134696906,0.109281151381265
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20612.Liking for beetroot,33122,-0.033698942515157,0.0744590097202714,-0.179638601566889,0.112240716536575,0.650859792769287
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20613.Liking for bell pepper,33122,0.067281379347607,0.0726656404057429,-0.075143275847649,0.209706034542863,0.35452186907332
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20614.Liking for bicycling,33122,0.152112413640469,0.07173313132688,0.0115154762397839,0.292709351041153,0.0339895342135592
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20615.Liking for biscuits,33122,-0.0989048232940838,0.0721260742418269,-0.240271928808065,0.042462282219897,0.170324164068468
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20616.Liking for bitter foods,33122,-0.0287523665759628,0.0722251392439446,-0.170313639494094,0.112808906342169,0.690570994972627
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20617.Liking for bitter or ale,33122,-0.0430777182959425,0.0739958987268625,-0.188109679800593,0.101954243208708,0.560471646745125
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20618.Liking for black olives,33122,0.0455921708952725,0.0730873781088222,-0.0976590901980189,0.188843431988564,0.532772991707493
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20619.Liking for black pepper,33122,-0.0258496318173452,0.073412511841984,-0.169738155027634,0.118038891392943,0.724760737550639
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20620.Liking for blue cheese,33122,-0.0538873820500083,0.0722225048620967,-0.195443491579718,0.0876687274797012,0.455609101413985
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20621.Liking for bolognese sauce,33122,-0.0674370136635066,0.0717117954866715,-0.207992132817383,0.0731181054903695,0.347044074033466
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20622.Liking for broad beans,33122,-0.00263851380486251,0.0724123024595843,-0.144566626625648,0.139289599015923,0.970934457310676
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20623.Liking for broccoli,33122,0.060886925239454,0.0752258453405729,-0.086555731628069,0.208329582106977,0.418314017457533
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20624.Liking for brown rice,33122,0.13572077198079,0.0723563676884886,-0.00609770868864784,0.277539252650228,0.0607264256670037
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20625.Liking for brussel sprouts,33122,-0.0649631202963727,0.0727258998206142,-0.207505883944776,0.0775796433520311,0.371742897338969
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20626.Liking for burgers (meat),33122,-0.124612621398647,0.0712728513905413,-0.264307410124108,0.0150821673268139,0.0804322362636287
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20627.Liking for burn of spicy foods,33122,-0.0505693244640657,0.0717768988479419,-0.191252046206032,0.0901133972779004,0.481118717398955
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20628.Liking for butter on bread,33122,0.0495646472314226,0.0734265978087411,-0.09435148447371,0.193480778936555,0.4996791291884
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20629.Liking for butternut squash,33122,0.0682398907978402,0.0733153174969092,-0.0754581314961019,0.211937913091782,0.351997133543962
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20630.Liking for cabbage,33122,-0.00785325471905865,0.0740651519509368,-0.153020952542895,0.137314443104777,0.915559648573054
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20631.Liking for cake,33122,-0.145253808187815,0.0715079378991766,-0.285409366470201,-0.00509824990542884,0.0422554219577296
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20632.Liking for cake icing,33122,-0.123760852054354,0.0715826857100855,-0.264062916046122,0.0165412119374133,0.0838587615100071
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20633.Liking for capers,33122,-0.108428777675242,0.0712588217099628,-0.248096068226769,0.0312385128762855,0.128141078055997
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20634.Liking for cauliflower,33122,0.0491408904063409,0.0740948071636158,-0.0960849316343459,0.194366712447028,0.507209627678326
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20635.Liking for cereal or granola bar,33122,-0.0647075644772034,0.0717107248198692,-0.205260585124147,0.0758454561697403,0.366900568883367
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20636.Liking for cheesecake,33122,0.0105053203428093,0.0719016163234902,-0.130421847651231,0.15143248833685,0.883840420852654
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20637.Liking for cherries,33122,0.04006442129665,0.0783705154577271,-0.113541789000495,0.193670631593795,0.609211419523834
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20638.Liking for chicken,33122,-0.0820711282552424,0.0763682579064155,-0.231752913751817,0.0676106572413319,0.282549783560159
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20639.Liking for chilli pepper,33122,0.0124447653414016,0.0725793950653994,-0.129810848986781,0.154700379669584,0.863862811345201
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20640.Liking for chips or french fries,33122,-0.0902729661457004,0.0726312334181698,-0.232630183645313,0.0520842513539124,0.213940330649735
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20641.Liking for cigarette smoking,33122,0.104285608287502,0.120254269434038,-0.131412759803212,0.339983976378215,0.385851423780038
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20642.Liking for cod,33122,-0.0800133100565891,0.0746860930939596,-0.22639805252075,0.0663714324075718,0.284051782250181
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20643.Liking for coffee with sugar,33122,-0.0792294421325213,0.0821014240023711,-0.240148233177169,0.0816893489121261,0.334562189845335
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20644.Liking for coffee without sugar,33122,0.0395160158897966,0.0730380986430035,-0.10363865745049,0.182670689230083,0.588498805853634
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20645.Liking for coriander,33122,-0.0318686712289421,0.072657297764536,-0.174276974847433,0.110539632389548,0.660950563274648
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20646.Liking for corn flakes,33122,-0.00658668551048568,0.0718539598001363,-0.147420446718753,0.134247075697781,0.92696419997486
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20647.Liking for cream,33122,-0.00089863326015195,0.0719382268223416,-0.141897557831942,0.140100291311638,0.990033584490937
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20648.Liking for croissant,33122,0.0221511173457902,0.0724267189545029,-0.119805251805035,0.164107486496616,0.759732459105685
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20649.Liking for cucumber,33122,0.0162862031129419,0.072891242118783,-0.126580631439873,0.159153037665757,0.823204922031582
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20650.Liking for curry,33122,-0.0323270154101097,0.0727694425264187,-0.17495512276189,0.110301091941671,0.65688098658056
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20651.Liking for dairy products,33122,0.0928422782098305,0.0732518666392664,-0.0507313804031317,0.236415936822793,0.205032410227185
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20652.Liking for dark chocolate,33122,0.0314259518849495,0.0723244528162015,-0.110329975634805,0.173181879404704,0.663926410862278
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20653.Liking for diet fizzy drinks,33122,-0.092344074621824,0.0762323920701365,-0.241759563079292,0.0570714138356435,0.22579451156715
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20654.Liking for dried fruit,33122,0.0173960504629789,0.0726540975824239,-0.125005980798572,0.15979808172453,0.810772714404185
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20655.Liking for eggs,33122,0.0417751898542014,0.0745399836651775,-0.104323178129547,0.187873557837949,0.575193837711624
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20656.Liking for exercising alone,33122,0.046666661569042,0.0720222584517283,-0.0944969649963456,0.187830288134429,0.517035909749862
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20657.Liking for exercising with others,33122,0.140368777854341,0.0722066302012889,-0.00115621734018573,0.281893773048867,0.0519293136926822
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20658.Liking for extra virgin olive oil,33122,0.0726576364656767,0.0737209980835961,-0.0718355197781716,0.217150792709525,0.324368817562684
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20659.Liking for fatty foods,33122,-0.0787676831350826,0.071580206815539,-0.219064888493539,0.0615295222233739,0.271183450745181
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20660.Liking for fresh tomatoes,33122,0.0451424416221348,0.0799428470245361,-0.111545538545956,0.201830421790226,0.572303385657992
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20661.Liking for fried chicken,33122,-0.174311606034481,0.0719842065137716,-0.315400650801473,-0.0332225612674885,0.0154759142918839
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20662.Liking for fried or battered fish,33122,-0.0808340751379374,0.0721379673900025,-0.222224491222342,0.0605563409464674,0.26251126151699
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20663.Liking for fruit,33122,0.140514709044552,0.085022119200505,-0.0261286445884375,0.307158062677542,0.0984314069861258
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20664.Liking for garlic,33122,0.0340071803429647,0.0739169470568117,-0.110870035888386,0.178884396574316,0.645475481734756
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20665.Liking for gherkins,33122,-0.0797313727669107,0.0729384860414713,-0.222690805408194,0.0632280598743731,0.274366373314404
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20666.Liking for globe artichoke,33122,0.0975430463826333,0.0724092069576363,-0.0443789992543339,0.239465092019601,0.177980586711667
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20667.Liking for goat's cheese,33122,0.000589365938065488,0.0729938680837101,-0.142478615506006,0.143657347382137,0.993557989024064
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20668.Liking for going to a cafe,33122,0.0339067616836247,0.0725198235002304,-0.108232092376827,0.176045615744076,0.640117025462135
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20669.Liking for going to the gym,33122,0.178186406252251,0.070077902567704,0.0408337172195508,0.31553909528495,0.0110175199756911
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20670.Liking for going to the pub,33122,-0.0108454919698428,0.0711532494957849,-0.150305860981581,0.128614877041896,0.87885575727616
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20671.Liking for grapefruit,33122,0.0158060055817007,0.0709759807703084,-0.123306916728104,0.154918927891505,0.82377803972893
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20672.Liking for green olives,33122,0.0617347133986926,0.0738750802715,-0.0830604439334473,0.206529870730833,0.403367246821382
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20673.Liking for haddock,33122,-0.115951633502372,0.0745784561227022,-0.262125407502868,0.0302221404981247,0.120039671046196
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20674.Liking for ham,33122,-0.17116473419126,0.0725653101513116,-0.313392742087831,-0.0289367262946892,0.0183577969085615
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20675.Liking for hard cheese,33122,0.122514122129623,0.0743655273443069,-0.0232423114652183,0.268270555724465,0.0995001096005188
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20676.Liking for herring,33122,-0.012782947147755,0.0717122875098322,-0.153339030667026,0.127773136371516,0.858528273568978
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20677.Liking for honey,33122,0.0561458902214075,0.0719703028192245,-0.0849159033042726,0.197207683747088,0.435338148950052
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20678.Liking for horseradish or wasabi,33122,-0.0665470291478576,0.0731535299282404,-0.209927947807209,0.0768338895114936,0.363011373137269
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20679.Liking for ice cream,33122,-0.00678488231804959,0.0719856439862072,-0.147876744531016,0.134306979894916,0.92491015025093
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20680.Liking for jam,33122,-0.0948693271402031,0.0720306459110892,-0.236049393125938,0.0463107388455318,0.187850358378821
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20681.Liking for kiwi fruit,33122,0.0214405564847331,0.072750205568436,-0.121149846429401,0.164030959398868,0.768218880697766
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20682.Liking for lager,33122,0.0188762471014404,0.0724743972696719,-0.123173571547117,0.160926065749997,0.79451978085957
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20683.Liking for lamb,33122,-0.0954696146589647,0.0726020890756704,-0.237769709247279,0.0468304799293492,0.188554588742295
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20684.Liking for lemons,33122,0.00770049315723961,0.073671685645871,-0.136696010708667,0.152096997023147,0.916755578649403
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20685.Liking for lentils or beans,33122,0.0842910345593568,0.0725933957680575,-0.0579920211460359,0.226574090264749,0.24561731251376
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20686.Liking for liver,33122,-0.0824437198327745,0.0726212258757063,-0.224781322549159,0.0598938828836098,0.256299271439857
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20687.Liking for mackerel,33122,0.00385813275236308,0.0726434868894889,-0.138523101551035,0.146239367055761,0.957645081127239
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20688.Liking for marzipan,33122,0.0610801075895483,0.071913500372962,-0.0798703531414573,0.202030568320554,0.395707133462741
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20689.Liking for mayonnaise,33122,0.0842067329718294,0.0728469025038827,-0.0585731959357807,0.226986661879439,0.247737110794624
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20690.Liking for melon,33122,0.0996624283544067,0.0759368512169297,-0.0491738000307755,0.248498656739589,0.189407085538241
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20691.Liking for milk chocolate,33122,-0.0422380603551272,0.0727684972421208,-0.184864314949684,0.10038819423943,0.561630130943214
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20692.Liking for mushrooms,33122,0.0459662646546138,0.0753960328459047,-0.101809959723359,0.193742489032587,0.542100244541878
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20694.Liking for orange juice,33122,0.0957841452084308,0.072465270025063,-0.0462477840406926,0.237816074457554,0.186271731397484
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20695.Liking for oranges,33122,0.00606541010673014,0.0729295948774556,-0.136876595853083,0.149007416066543,0.933719861857105
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20696.Liking for pasta,33122,0.0142439999697905,0.0724877416865931,-0.127831973735932,0.156319973675513,0.844221729360859
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20697.Liking for pears,33122,0.146598784113881,0.073783958451167,0.00198222554959382,0.291215342678169,0.0469687843111699
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20698.Liking for pizza,33122,0.019539767907028,0.0714903180603805,-0.120581255491318,0.159660791305374,0.784613392177196
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20699.Liking for plain yogurt,33122,0.0686277081434592,0.0714556170461672,-0.0714253012670285,0.208680717553947,0.336868543855753
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20700.Liking for plums,33122,0.131329046113852,0.0746134717557076,-0.014913358527335,0.277571450755039,0.0784218881965657
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20701.Liking for pollock,33122,-0.116153625343019,0.0709398506091495,-0.255195732536952,0.0228884818509141,0.101592919772706
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20702.Liking for pork chop,33122,-0.129712544831161,0.0716374458982033,-0.270121938791639,0.0106968491293178,0.0702249190011228
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20703.Liking for porridge,33122,0.0360331664523175,0.0745608766689313,-0.110106151818788,0.182172484723423,0.628915001630434
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20704.Liking for potato crisps,33122,-0.00906508735727362,0.0732414840864423,-0.152618396166701,0.134488221452153,0.901500378049462
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20705.Liking for potatoes,33122,0.0250332533884514,0.0729124437443715,-0.117875136350517,0.16794164312742,0.731356234769144
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20706.Liking for prawns,33122,0.089558254143368,0.0732245377434385,-0.0539618398337715,0.233078348120507,0.221339017554538
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20707.Liking for raw carrots,33122,0.104708120063863,0.072946159747562,-0.0382663530413584,0.247682593169085,0.151204563245265
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20708.Liking for red meat,33122,-0.170358799142278,0.0719584940589865,-0.311397447497892,-0.0293201507866649,0.0179325451843782
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20709.Liking for red wine,33122,-0.0486193384482899,0.071817430398804,-0.189381502029946,0.0921428251333661,0.498433416643146
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33122,-0.138909561766196,0.0765368204280657,-0.288921729805204,0.0111026062728129,0.0695680569340068
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20711.Liking for roast chicken,33122,-0.0485505239504202,0.0769239687287698,-0.199321502658809,0.102220454757969,0.527959437002222
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20712.Liking for salad dressing,33122,0.161539842300984,0.0732496951828806,0.0179704397425376,0.305109244859429,0.0274570340639509
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20713.Liking for salad leaves,33122,0.171446774279952,0.0753905083965352,0.0236813778227433,0.319212170737161,0.0229833577963706
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20714.Liking for salami,33122,-0.133235002918085,0.0731328844982075,-0.276575456534572,0.0101054506984014,0.0685166696406484
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20715.Liking for salmon,33122,-0.00763120575310587,0.078248018249155,-0.16099732152145,0.145734910015238,0.922311050617889
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20716.Liking for salty foods,33122,-0.0889660069840352,0.0725709342724245,-0.231205038157987,0.0532730241899168,0.220262905327026
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20717.Liking for salty pretzels,33122,-0.0701124056803671,0.0722602125441924,-0.211742422266984,0.0715176109062499,0.331935647745242
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20718.Liking for sardines,33122,0.0227404338466702,0.0720249316041891,-0.11842843209754,0.163909299790881,0.752215038299384
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20719.Liking for sausages (meat),33122,-0.141813185355104,0.0725218575730278,-0.283956026198238,0.000329655488030961,0.0505615707641735
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20720.Liking for savoury biscuits,33122,0.11250397688997,0.0733234221603823,-0.0312099305443793,0.256217884324319,0.124979480172359
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33122,-0.112913849868392,0.0714422612866765,-0.252940681990278,0.0271129822534941,0.11403098627175
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20722.Liking for skimmed milk,33122,-0.0498290464586476,0.0722062895815536,-0.191353374038493,0.0916952811211974,0.490154269931669
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20723.Liking for smoked fish,33122,-0.085522785801458,0.0719076572650437,-0.226461794040944,0.0554162224380276,0.234337779447118
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20724.Liking for soft cheese,33122,-0.00134150059935598,0.0729059518935041,-0.144237166310624,0.141554165111912,0.985319836156282
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20725.Liking for soy sauce,33122,-0.0470362518279211,0.0725174570052607,-0.189170467558232,0.0950979639023899,0.516601409972908
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20726.Liking for soya milk,33122,-0.00239089959723146,0.0719135334322783,-0.143341425124497,0.138559625930034,0.973478491353969
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20727.Liking for spicy foods,33122,-0.0122002350412816,0.0723792666704716,-0.154063597715406,0.129663127632843,0.866146835436571
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20728.Liking for spinach,33122,-0.0252962903584918,0.0742528234150998,-0.170831824252087,0.120239243535104,0.733354397350424
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20729.Liking for spirits,33122,-0.0616789513108018,0.0727849631688675,-0.204337479121782,0.0809795765001785,0.396788167788958
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20730.Liking for strawberries,33122,-0.0482291243525779,0.0824209531861596,-0.209774192597451,0.113315943892295,0.558457997649943
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33122,-0.255589446051794,0.0750290841503217,-0.402646450986425,-0.108532441117164,0.000660914683396207
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20732.Liking for sweet foods,33122,-0.192719727904634,0.0729089210474352,-0.335621213157607,-0.0498182426516608,0.00822515046735469
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20733.Liking for taking the stairs,33122,-0.0148139151513734,0.0735232547217494,-0.158919494406002,0.129291664103255,0.84032321506063
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20734.Liking for tea with sugar,33122,-0.0913765331803837,0.096623282898218,-0.280758167660891,0.0980051013001235,0.344328561322504
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20735.Liking for tea without sugar,33122,-0.0414603450534239,0.0762820557481049,-0.190973174319709,0.108052484212862,0.58679012511142
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20736.Liking for tomato ketchup,33122,-0.120250927981454,0.0715110011679548,-0.260412490270645,0.0199106343077376,0.0926878331631068
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20737.Liking for tinned tuna,33122,0.0274415020565165,0.0725021531734128,-0.114662718163373,0.169545722276406,0.705074237259647
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20738.Liking for turnip (white),33122,0.00553765090646079,0.0718362646473488,-0.135261427802343,0.146336729615265,0.938556018180212
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20739.Liking for vegetables,33122,0.158115427352892,0.0845865307522141,-0.00767417292144723,0.323905027627232,0.0616183833904348
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20740.Liking for vinegar,33122,-0.00163612763447832,0.0734648412150078,-0.145627216415894,0.142354961146937,0.982232380003217
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20741.Liking for watching television,33122,-0.224564796615526,0.0735192429008303,-0.368662512701153,-0.0804670805298988,0.00226118324907652
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20742.Liking for whisky,33122,-0.0510992537507585,0.0760004616939809,-0.200060158670961,0.0978616511694441,0.501375966371283
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20743.Liking for white bread,33122,-0.000444039302850443,0.0718497888826999,-0.141269625512942,0.140381546907241,0.995069162656299
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20744.Liking for white rice,33122,-0.0640975969887488,0.072155334176071,-0.205522051973848,0.0773268579963503,0.374389061792612
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20745.Liking for white wine,33122,0.0113544983850411,0.0726020591682185,-0.130945537584667,0.153654534354749,0.875726415966491
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33122,0.0233498650143135,0.0730483233500398,-0.119824848751765,0.166524578780392,0.749241703964611
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20747.Liking for whole milk,33122,-0.134292454380818,0.0713365582625277,-0.274112108575372,0.00552719981373662,0.0597990216585941
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20748.Liking for wholemeal bread,33122,0.19463389369484,0.0769315652392455,0.0438480258259185,0.345419761563761,0.0114250828168778
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X20749.Liking for working up a sweat,33122,0.091456107542262,0.0721097400245233,-0.0498789829058036,0.232791197990328,0.204728272034491
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21001.Body mass index (BMI),47692,-0.00436062604384588,0.00679694063708672,-0.0176826296925358,0.00896137760484409,0.52116707262501
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21002.Weight,47699,0.00428261851371377,0.00420991064080137,-0.00396880634225692,0.0125340433696844,0.309035283843984
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X21021.Pulse wave Arterial Stiffness index,32211,8.40823818976484e-05,0.0030469452168424,-0.00588793024311346,0.00605609500690875,0.977985374418896
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32659,-0.0592141504876786,0.0755255672261631,-0.207244262250958,0.0888159612756011,0.433046391108723
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32671,-0.101367829376266,0.0789941953162423,-0.256196452196101,0.053460793443569,0.199447223425305
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32672,-0.0147946679606955,0.0789882007653521,-0.169611541460786,0.140022205539395,0.851428281087384
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21040.Satisfaction with bowel habits,32626,-0.00774369661010333,0.072771995560087,-0.150376807907874,0.134889414687667,0.915259362038189
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32610,0.0164867074228507,0.0762737115075713,-0.133009767131989,0.165983181977691,0.828874758094614
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21042.Greatest number of times bowels opened per day,32626,0.0789968273644631,0.0792276245553661,-0.0762893167640545,0.234282971492981,0.318751845018076
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21043.Least number of times bowels opened per week,32544,0.0280391212651667,0.0782099623162876,-0.125252404874757,0.18133064740509,0.719970391753489
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21044.Average number of times bowels opened per day,32597,0.0745718063079959,0.0876778081822785,-0.0972766977292699,0.246420310345262,0.395060584422829
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32674,-0.0292875282786709,0.0784133630707064,-0.182977719897255,0.124402663339914,0.708784674422049
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32669,0.0102774417144947,0.0808559204208299,-0.148200162310332,0.168755045739321,0.898857958042136
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32672,0.0582538024705173,0.0923030599895997,-0.122660195109098,0.239167800050133,0.527983192139703
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32671,0.0310512649585876,0.0824840938784519,-0.130617559043178,0.192720088960353,0.706590947086454
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32668,0.199886979033928,0.12594526055467,-0.0469657316532248,0.446739689721081,0.11252982184073
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32669,-0.0489412888224429,0.0900448909357666,-0.225429275056545,0.12754669741166,0.58678588512794
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32670,-0.0240484191999849,0.231320053079738,-0.477435723236272,0.429338884836302,0.917202303195258
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32674,-0.0117359613269803,0.0859148890156732,-0.1801291437977,0.156657221143739,0.891350436471734
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32672,0.0195077759452155,0.0907341886088933,-0.158331233728215,0.197346785618646,0.829773293939162
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32447,-0.060780801973277,0.0796551123889483,-0.216904822255616,0.0953432183090616,0.445456332677488
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32670,-0.132624853218895,0.0808990053770618,-0.291186903757936,0.0259371973201462,0.101170774079692
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32671,0.216122758137394,0.108982627295843,0.00251680863754222,0.429728707637245,0.047390202689383
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32674,-0.0051750585530251,0.0795591461636874,-0.161110985033852,0.150760867927802,0.94813841291425
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32673,-0.0819159906160453,0.0797336299675734,-0.238193905352489,0.0743619241203985,0.304276200194192
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X21100.Water hardness (USGS classification),47576,-0.0710630189377041,0.0472776321179333,-0.163727177888853,0.0216011400134452,0.132826860942477
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2139.Age first had sexual intercourse,44455,0.00113268201373525,0.00217932251640582,-0.00313879011842015,0.00540415414589065,0.603250257476821
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2149.Lifetime number of sexual partners,43189,0.0289250944478861,0.0521701442581633,-0.0733283882981139,0.131178577193886,0.57928595339043
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22032.IPAQ activity group,42432,-0.00636414163631019,0.0538710870072824,-0.111951472170584,0.0992231888979632,0.905960823345273
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22033.Summed days activity,43018,0.00102861554782189,0.00200223169487271,-0.00289575857412862,0.00495298966977241,0.607443724342204
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22034.Summed minutes activity,42432,-7.03602378666229e-05,0.00201615044770906,-0.00402201511537638,0.00388129463964314,0.97216121777627
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22037.MET minutes per week for walking,41541,-0.000559220319203634,0.00205324445404893,-0.00458357944913954,0.00346513881073227,0.785349018301619
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22038.MET minutes per week for moderate activity,42432,0.00190756892418659,0.00198912922801069,-0.00199112436271435,0.00580626221108754,0.337573161247762
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22039.MET minutes per week for vigorous activity,42432,-0.0173183800272294,0.0537571470203351,-0.122682388187086,0.0880456281326273,0.747335547848192
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X22040.Summed MET minutes per week for all activity,41541,0.00080138046115195,0.00209174820839607,-0.00329844602730435,0.00490120694960825,0.701639140826216
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X2217.Age started wearing glasses or contact lenses,44502,0.000506363314574156,0.00195526522028465,-0.00332595651718377,0.00433868314633208,0.795657778577302
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X22501.Year ended full time education,30075,0.0051854028505116,0.00938658684228043,-0.0132123073603581,0.0235831130613812,0.580677877955236
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X22506.Tobacco smoking,30044,0.0851243647280642,0.203140789899033,-0.313031583474041,0.483280312930169,0.675202107237678
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46195,0.241939370830063,0.105190784092573,0.0357654340086197,0.448113307651507,0.0214573393367485
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23098.Weight,47338,0.00403040016299271,0.00424010144086988,-0.00428019866111226,0.0123409989870977,0.341846283469369
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23099.Body fat percentage,47339,-0.00652330365015855,0.00434880459352473,-0.015046960653467,0.00200035335314992,0.133622432889109
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23100.Whole body fat mass,47333,-0.00238917434533889,0.00417126502645584,-0.0105648537971923,0.00578650510651455,0.566806244761106
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23101.Whole body fat-free mass,47338,0.00587455143844981,0.00347746240988214,-0.000941274884919185,0.0126903777618188,0.0911714882762547
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23102.Whole body water mass,47338,0.00573549051975223,0.00348960775464858,-0.00110414067935898,0.0125751217188634,0.100274295240336
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23104.Body mass index (BMI),47338,-0.00581982213592077,0.00688004426531667,-0.0193047088959414,0.0076650646240999,0.397617969116679
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23105.Basal metabolic rate,47336,0.00624846845287057,0.00379158298677454,-0.00118303420120752,0.0136799711069487,0.0993696635900509
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23106.Impedance of whole body,47332,-0.00430620886749643,0.00284664021360675,-0.00988562368616565,0.0012732059511728,0.13036110215326
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23107.Impedance of leg (right),47335,-0.00230851951844417,0.00233650264407491,-0.006888064700831,0.00227102566394266,0.323151586356375
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23108.Impedance of leg (left),47334,-0.00237982154160871,0.00230667722108392,-0.00690090889493319,0.00214126581171577,0.302218979911748
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23109.Impedance of arm (right),47327,-0.00370536790928911,0.00285752328900455,-0.00930611355573804,0.00189537773715981,0.194745405995797
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23110.Impedance of arm (left),47333,-0.00333134681569977,0.00286215166097357,-0.00894116407120796,0.00227847043980842,0.244464144396663
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23111.Leg fat percentage (right),47334,-0.00968615025732815,0.00686319363369189,-0.0231380097793643,0.00376570926470796,0.158164399382679
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23112.Leg fat mass (right),47333,-0.00611081162093478,0.00789805558549823,-0.0215910005685113,0.00936937732664174,0.439109771791728
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23113.Leg fat-free mass (right),47333,0.00482297512442735,0.00354027769540877,-0.00211596915857383,0.0117619194074285,0.173111752543727
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23114.Leg predicted mass (right),47332,0.00476863694878146,0.00355396366036791,-0.00219713182553964,0.0117344057231026,0.179680692282062
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23115.Leg fat percentage (left),47329,-0.0117818042059266,0.00706267839821583,-0.0256246538664297,0.00206104545457639,0.0952940967538173
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23116.Leg fat mass (left),47329,-0.00541151048379026,0.00790875301418123,-0.0209126663915855,0.0100896454240049,0.493828537355818
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23117.Leg fat-free mass (left),47327,0.00541686924578284,0.00362680778126186,-0.0016916740054904,0.0125254124970561,0.135303428215714
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23118.Leg predicted mass (left),47326,0.00515569792610704,0.00364113716266734,-0.00198093091272096,0.012292326764935,0.156801367080264
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23119.Arm fat percentage (right),47326,-0.00649509892908437,0.00484558438294612,-0.0159924443196588,0.00300224646149003,0.180123443384205
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23120.Arm fat mass (right),47324,-0.00326919085482888,0.00435889450536321,-0.0118126240853408,0.00527424237568301,0.453259659232105
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23121.Arm fat-free mass (right),47325,0.00347250833748309,0.00339205094631468,-0.00317591151729369,0.0101209281922599,0.305978659172422
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23122.Arm predicted mass (right),47324,0.0047731426579914,0.00338732561742857,-0.00186601555216859,0.0114123008681514,0.158813773163034
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23123.Arm fat percentage (left),47322,-0.00868650137315828,0.00543481254801674,-0.0193387339672711,0.00196573122095454,0.109988385319685
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23124.Arm fat mass (left),47322,-0.00582085338609808,0.00447547958724206,-0.0145927933770925,0.00295108660489636,0.193405096668408
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23125.Arm fat-free mass (left),47322,0.00371246879829454,0.00365373695725243,-0.00344885563792022,0.0108737932345093,0.309604679915771
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23126.Arm predicted mass (left),47320,0.00436495825144137,0.00366196800163616,-0.00281249903176551,0.0115424155346482,0.233285136858956
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23127.Trunk fat percentage,47319,-0.00315875613208333,0.00274806290758472,-0.00854495943094938,0.00222744716678272,0.250383211104374
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23128.Trunk fat mass,47315,-0.00190830665865604,0.00317048468703469,-0.00812245664524402,0.00430584332793195,0.547248368102331
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23129.Trunk fat-free mass,47310,0.00609339461106557,0.00325116676903119,-0.000278892256235571,0.0124656814783667,0.06091315720923
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X23130.Trunk predicted mass,47307,0.00611001308477156,0.00325837250593518,-0.000276397026861404,0.0124964231964045,0.0607816279336074
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23400.Total Cholesterol,37482,0.00294969168381983,0.00243526496505808,-0.001823427647694,0.00772281101533366,0.225825191400409
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37482,0.00125200181666192,0.00235265742860551,-0.00335920674340487,0.00586321037672871,0.594620831551633
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37482,6.47255460582542e-05,0.00234904249220333,-0.00453939773866027,0.00466884883077678,0.978018282448477
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23403.VLDL Cholesterol,37482,-0.00227333908017893,0.00230216435286473,-0.0067855812117938,0.00223890305143595,0.323426181731609
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23404.Clinical LDL Cholesterol,37482,0.00253330450899717,0.00235398651067669,-0.00208050905192915,0.00714711806992348,0.281868339227302
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23405.LDL Cholesterol,37482,0.00233449815647523,0.00235345394685078,-0.00227827157935231,0.00694726789230276,0.321242510046166
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23406.HDL Cholesterol,37482,0.00682367845638369,0.00272826313305857,0.00147628271558889,0.0121710741971785,0.0123927454291798
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23407.Total Triglycerides,37482,-0.00486580157360289,0.0024885508845414,-0.00974336130730404,1.17581600982582e-05,0.0505719543337408
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23408.Triglycerides in VLDL,37482,-0.00482078402208114,0.0024907438763756,-0.00970264201977733,6.10739756150376e-05,0.0529530748994316
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23409.Triglycerides in LDL,37482,-0.00173083268718601,0.00248035408149602,-0.00659232668691822,0.0031306613125462,0.485304238284342
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23410.Triglycerides in HDL,37482,-0.005600978855736,0.00234220112617419,-0.0101916930630374,-0.00101026464843458,0.0168014950725556
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37482,0.00190475175832482,0.00248275033575925,-0.0029614388997633,0.00677094241641294,0.442979937373722
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23412.Phospholipids in VLDL,37482,-0.00352004996270065,0.00237160768510879,-0.00816840102551388,0.00112830110011259,0.137767776296379
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23413.Phospholipids in LDL,37482,0.00244504779473467,0.00233611797704342,-0.00213374344027044,0.00702383902973978,0.29529033864619
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23414.Phospholipids in HDL,37482,0.00373619134581923,0.00263972757751679,-0.00143767470611368,0.00891005739775214,0.156983926425926
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23415.Total Esterified Cholesterol,37482,0.00341475873746621,0.00244378752681496,-0.00137506481509111,0.00820458229002353,0.162340473608632
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37482,-0.00171932921542618,0.00228744420757081,-0.00620271986226497,0.0027640614314126,0.45228256386505
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37482,0.00189529871527713,0.00234848565538696,-0.00270773316928131,0.00649833059983556,0.419663847187561
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37482,0.00707236621426049,0.00270981953477749,0.00176111992609661,0.0123836125024244,0.00906714735663111
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23419.Total Free Cholesterol,37482,0.0018096469010369,0.00241265273316228,-0.00291915245596116,0.00653844625803496,0.45322896866498
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23420.Free Cholesterol in VLDL,37482,-0.00299227225652206,0.00234390968175981,-0.00758633523277129,0.00160179071972718,0.201760653700383
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23421.Free Cholesterol in LDL,37482,0.00341725393298877,0.0023728310168464,-0.00123349486003017,0.0080680027260077,0.149846446930118
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23422.Free Cholesterol in HDL,37482,0.00532438913566713,0.00273790563811106,-4.19059150305505e-05,0.0106906841863648,0.0518332846141008
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37482,0.000793677264697291,0.00242493085765436,-0.00395918721630526,0.00554654174569984,0.743447062748404
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23424.Total Lipids in VLDL,37482,-0.00391473089919651,0.00241956677228926,-0.00865708177288347,0.00082761997449044,0.105698215890979
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23425.Total Lipids in LDL,37482,0.00214615718602857,0.00234876534258311,-0.00245742288543433,0.00674973725749147,0.360871205979934
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23426.Total Lipids in HDL,37482,0.00471399600780043,0.00267388524728906,-0.00052681907688612,0.00995481109248699,0.0779279441259567
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37482,0.00474083101595265,0.00249861563922712,-0.000156455636932501,0.00963811766883781,0.0577994843451027
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23428.Concentration of VLDL Particles,37482,-0.00304157997440455,0.00233560178722975,-0.00761935947737485,0.00153619952856575,0.1928477308377
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23429.Concentration of LDL Particles,37482,0.000706783439336919,0.00232890874163208,-0.00385787769426196,0.0052714445729358,0.761526899070882
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23430.Concentration of HDL Particles,37482,0.00486870357848415,0.00250328828079922,-3.77414518823171e-05,0.00977514860885062,0.0518057003919482
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37482,-0.00449750872663166,0.00262841716202556,-0.00964920636420176,0.000654188910938431,0.0870847610244288
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23432.Average Diameter for LDL Particles,37482,0.00497996973187041,0.00239619361404407,0.00028343024834403,0.0096765092153968,0.0377027774849299
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23433.Average Diameter for HDL Particles,37482,0.00362552460575358,0.00285083838536541,-0.00196211862956262,0.00921316784106978,0.203488286399796
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23434.Phosphoglycerides,37470,0.00153251899471589,0.00249560463637512,-0.00335886609257934,0.00642390408201112,0.539168402373923
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37470,-0.00662638170006302,0.00264085881437982,-0.0118024649762475,-0.00145029842387858,0.0121133365778338
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23436.Total Cholines,37470,0.00231166145586304,0.00250281740075227,-0.00259386064961141,0.00721718356133749,0.355699391384694
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23437.Phosphatidylcholines,37470,0.00145713671942305,0.00250423090092906,-0.0034511558463979,0.00636542928524401,0.560664355835045
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23438.Sphingomyelins,37469,0.00441351281288494,0.00251553685740526,-0.000516939427629366,0.00934396505339924,0.0793681654678164
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23439.Apolipoprotein B,37482,0.000525228486237583,0.00232824791932234,-0.00403813743563421,0.00508859440810937,0.821524178570267
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23440.Apolipoprotein A1,37482,0.00427916637502579,0.0025891419489187,-0.000795551844854859,0.00935388459490643,0.0984088329066594
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37482,-0.00143370382741457,0.00235083270615057,-0.00604133593146968,0.00317392827664055,0.541958143330829
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23442.Total Fatty Acids,37470,-0.00146459570494048,0.00249653367746343,-0.00635780171276881,0.00342861030288784,0.5574478309393
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23443.Degree of Unsaturation,37470,0.000177293036288573,0.00260507522665182,-0.00492865440794899,0.00528324048052614,0.945741478883217
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23444.Omega-3 Fatty Acids,37470,-0.00242187111523506,0.00243450449075784,-0.00719349991712042,0.0023497576866503,0.319846831796525
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23445.Omega-6 Fatty Acids,37470,-0.000176546517836979,0.00241696267674282,-0.00491379336425291,0.00456070032857895,0.941771602010529
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37470,-0.00063497810783946,0.00243922287944209,-0.00541585495154596,0.00414589873586704,0.794621187687568
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37470,-0.00264786011522876,0.00255797935224449,-0.00766149964562796,0.00236577941517045,0.300623973137939
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23448.Saturated Fatty Acids,37470,-0.00093516716268681,0.00254759231734693,-0.0059284481046868,0.00405811377931318,0.713566197578203
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23449.Linoleic Acid,37470,-0.000107623063093088,0.00239256803915213,-0.00479705641983126,0.00458181029364508,0.964122157209517
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23450.Docosahexaenoic Acid,37470,0.000823489972724178,0.00256015385735812,-0.00419441158769774,0.00584139153314609,0.747718146404254
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37470,-0.00239417635913499,0.00242484551871624,-0.00714687357581882,0.00235852085754884,0.323488399377598
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37470,0.00301920043276227,0.00272676320146813,-0.00232525544211527,0.0083636563076398,0.268207601346168
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37470,0.00253603225495832,0.00273241266635817,-0.0028194965711037,0.00789156108102033,0.353357710523235
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37470,-0.00434182715574065,0.00269478216441673,-0.00962360019799743,0.000939945886516138,0.107160855451326
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37470,0.00129495353297998,0.00254143765460289,-0.0036862642700417,0.00627617133600165,0.610385330619849
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37470,0.00275786798734053,0.00262019915556476,-0.0023777223575664,0.00789345833224746,0.292570780357336
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37470,0.00193613785504597,0.00258718876103023,-0.00313475211657328,0.00700702782666521,0.454259062353821
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37470,0.00357004904896944,0.00272185104173754,-0.00176477899283613,0.00890487709077501,0.189669678525805
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37468,0.00283142792898849,0.00241628724848451,-0.00190449507804114,0.00756735093601812,0.241295066775257
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23460.Alanine,37476,-0.00294886361468277,0.00233594938776419,-0.00752732441470057,0.00162959718533504,0.206833480771841
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23461.Glutamine,37440,0.000429151029977699,0.00236494254272659,-0.00420613635376641,0.00506443841372181,0.856006519398884
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23462.Glycine,37465,0.00546426878973106,0.00223820717811843,0.00107738272061893,0.00985115485884319,0.0146453034879364
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23463.Histidine,37465,-0.00209962592091899,0.00229282455233632,-0.00659356204349817,0.0023943102016602,0.359821446458693
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37473,-0.00299365955589187,0.00234677485102168,-0.00759333826389437,0.00160601915211063,0.202102597324691
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23465.Isoleucine,37479,-0.00319287400578977,0.00230073725356286,-0.00770231902277298,0.00131657101119344,0.165233493742762
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23466.Leucine,37480,-0.00208410171864841,0.00234355690999294,-0.00667747326223458,0.00250926982493776,0.373863665501191
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23467.Valine,37473,-0.00309086585952192,0.00236842566348469,-0.00773298015995191,0.00155124844090807,0.19190579237871
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23468.Phenylalanine,37479,-0.00367662387338751,0.00228840088589963,-0.00816188960975077,0.000808641862975764,0.108158800453924
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23469.Tyrosine,37465,-0.00337723042404154,0.00231642199641676,-0.00791741753701839,0.00116295668893531,0.144878103850869
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23470.Glucose,37458,-0.00127647491951955,0.00244474353256667,-0.00606817224335022,0.00351522240431112,0.601588433426297
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23471.Lactate,37455,0.000428529342140779,0.00230043518843543,-0.00408032362719267,0.00493738231147423,0.85222663923623
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23472.Pyruvate,37442,0.00322995544011459,0.0023542364307687,-0.00138434796419207,0.00784425884442124,0.170094660089046
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23473.Citrate,37481,0.00349618716180544,0.00234123609235979,-0.00109263557921975,0.00808500990283062,0.135380732820461
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23474.3-Hydroxybutyrate,37322,0.00134245041658872,0.00220906592385243,-0.00298731879416204,0.00567221962733949,0.543396868728796
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23475.Acetate,37473,0.00425563233174324,0.00237244779722803,-0.000394365350823691,0.00890563001431018,0.0728726338428608
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23476.Acetoacetate,37482,0.00063874976653499,0.00228403855477221,-0.00383796580081854,0.00511546533388852,0.779744305329642
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23477.Acetone,37482,0.00293651895603816,0.00229496746821342,-0.00156161728166014,0.00743465519373647,0.200727249583181
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23478.Creatinine,37098,0.00161051829119663,0.00273701268662007,-0.00375402657457871,0.00697506315697198,0.556259629284409
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23479.Albumin,37480,0.00423148982903933,0.00236636364459011,-0.000406582914357278,0.00886956257243594,0.0737698153365859
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23480.Glycoprotein Acetyls,37482,-0.00541214155090513,0.00252253383558017,-0.0103563078686423,-0.000467975233168009,0.0319298828707477
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37482,-0.0058827230239926,0.00251668964797297,-0.0108154347340196,-0.000950011313965577,0.0194290645189634
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37482,-0.00562477853773504,0.00251688000033909,-0.0105578633383997,-0.000691693737070418,0.025445926282811
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37482,-0.00601208954721168,0.00248275179547389,-0.0108782830663405,-0.00114589602808285,0.0154683467344583
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37482,-0.00539801135488753,0.00247255518917153,-0.0102442195256637,-0.000551803184111324,0.0290409843023903
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37482,-0.00415675958843026,0.00245502780343125,-0.00896861408315551,0.000655094906294988,0.0904485545996068
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37482,-0.00592961058754988,0.00248779776810201,-0.0108056942130298,-0.00105352696206993,0.0171641596315412
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37482,-0.00428949885543935,0.00253781128926121,-0.00926360898239132,0.00068461127151262,0.0910068195616088
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37482,-0.00515161829723727,0.00246696755712066,-0.00998687470919376,-0.000316361885280779,0.0367956311533917
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37482,-0.00495568946414068,0.00247201581147223,-0.00980084045462626,-0.000110538473655104,0.0450140751458812
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37482,-0.00485627312755657,0.00245636362496903,-0.00967074583249586,-4.18004226172778e-05,0.048060732746616
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37482,-0.00443124267148093,0.00238538340602011,-0.00910659414728034,0.00024410880431848,0.0632391795407687
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37482,-0.00374616893761118,0.00233538668956807,-0.0083235268491646,0.000831188973942243,0.10871859324138
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37482,-0.00506490879300738,0.00243742352325308,-0.00984225889858342,-0.000287558687431345,0.0377310542104888
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37482,-0.00509877389276708,0.00250098090954897,-0.0100006964754831,-0.000196851310051096,0.0414991575015408
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37482,-0.00466574191808895,0.00244596043321523,-0.0094598243671908,0.000128340531012899,0.0564740047571887
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23496.Total Lipids in Large VLDL,37482,-0.00452241885585584,0.00244025360104534,-0.00930531591390471,0.00026047820219303,0.0638680165965784
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23497.Phospholipids in Large VLDL,37482,-0.00476732046808462,0.00242829405148043,-0.00952677680898625,-7.86412718298268e-06,0.0496397003019759
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23498.Cholesterol in Large VLDL,37482,-0.00439958062458603,0.00236042930547972,-0.00902602206332627,0.000226860814154218,0.0623596244716145
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37482,-0.00389847333589179,0.00230419146207086,-0.00841468860155067,0.000617741929767089,0.0906879758952459
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37482,-0.0048359848192744,0.00241994482666847,-0.00957907667954459,-9.28929590042057e-05,0.0456955274898155
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23501.Triglycerides in Large VLDL,37482,-0.00437596766079376,0.00247687278142546,-0.00923063831238766,0.000478702990800132,0.0772967146078684
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37482,-0.00185235152792506,0.00232180865122557,-0.00640309648432717,0.00269839342847705,0.424997953847732
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37482,-0.0022945441309653,0.00234639786960168,-0.00689348395538459,0.00230439569345399,0.328141591557955
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37482,-0.00157018054931983,0.00231598103670925,-0.00610950338126996,0.00296914228263031,0.497798678165944
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37482,0.000147980391564111,0.00233211116602859,-0.00442295749385193,0.00471891827698015,0.949406436118199
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37482,0.00105928701650232,0.00237111947634923,-0.00358810715714218,0.00570668119014681,0.655066231981176
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37482,-0.00107728844925654,0.00230986950012976,-0.00560463266951088,0.00345005577099779,0.640947754822405
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37482,-0.00381059666662628,0.00243125578954072,-0.00857585801412609,0.000954664680873527,0.117060271245669
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37482,-0.00330067510224649,0.00233662183371101,-0.00788045389632007,0.00127910369182709,0.157801898772169
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23510.Total Lipids in Small VLDL,37482,-0.00306259103161488,0.00232343163499431,-0.00761651703620374,0.00149133497297397,0.187482427185835
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23511.Phospholipids in Small VLDL,37482,-0.00165864640439919,0.00229662242529553,-0.00616002635797842,0.00284273354918004,0.470177608067461
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23512.Cholesterol in Small VLDL,37482,-0.00142039453560076,0.00226915641030198,-0.00586794109979264,0.00302715202859113,0.531354053260406
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37482,-0.00189468022522621,0.00225534292314423,-0.0063151523545889,0.00252579190413649,0.400876028016442
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37482,-0.000604361675799435,0.00230083856922001,-0.00511400527147066,0.00390528191987179,0.792808957340576
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23515.Triglycerides in Small VLDL,37482,-0.00488596213170771,0.00240625470887683,-0.00960222136110629,-0.000169702902309134,0.0423233938796154
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37482,-0.00210301081214156,0.00234945605652248,-0.00670794468292563,0.00250192305864251,0.370747279878309
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37482,-0.00249001798952416,0.00234775285227319,-0.00709161357997962,0.0021115776009313,0.288893062920193
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37482,-0.00311644500877739,0.00234280296719067,-0.0077083388244711,0.00147544880691632,0.18346884654162
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37482,-0.00107632918316202,0.00238967671876221,-0.00576009555193595,0.00360743718561191,0.65242387045824
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37482,-0.000508174871409494,0.00240802916862399,-0.00522791204191252,0.00421156229909354,0.832864415399683
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37482,-0.00235734637700756,0.00235334251761893,-0.00696989771154067,0.00225520495752555,0.316506455953432
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37482,-0.00445777666855582,0.00238925901665152,-0.0091407243411928,0.000225171004081157,0.0620978279049318
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23523.Concentration of IDL Particles,37482,0.00159042309890847,0.00236268073515511,-0.00304043114199554,0.00622127733981249,0.500867961921756
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23524.Total Lipids in IDL,37482,0.00206206105380396,0.00242795048659143,-0.00269672189991524,0.00682084400752316,0.395729364334953
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23525.Phospholipids in IDL,37482,0.00138053642797374,0.00243326503747579,-0.0033886630454788,0.00614973590142629,0.570479624563891
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23526.Cholesterol in IDL,37482,0.00271657222384452,0.00243222486559375,-0.00205058851271923,0.00748373296040827,0.264054115247074
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37482,0.00285403741863809,0.00242824302633691,-0.00190531891298225,0.00761339375025843,0.239875868935557
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23528.Free Cholesterol in IDL,37482,0.00224264480980147,0.00243998648061502,-0.00253972869220396,0.0070250183118069,0.358048872392657
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23529.Triglycerides in IDL,37482,-0.00287533061487363,0.00242407865648791,-0.00762652478158993,0.00187586355184267,0.235583113301462
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23530.Concentration of Large LDL Particles,37482,0.00147785526828484,0.00234144707275616,-0.00311138099431723,0.0060670915308869,0.527939296286675
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23531.Total Lipids in Large LDL,37482,0.00256812046995597,0.00236791171620332,-0.00207298649380254,0.00720922743371447,0.278140736409955
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23532.Phospholipids in Large LDL,37482,0.00254306834131087,0.0023559635898912,-0.00207462029487588,0.00716075697749763,0.280421630631774
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23533.Cholesterol in Large LDL,37482,0.00283536065355656,0.002375122148493,-0.00181987875748971,0.00749060006460283,0.232587856600399
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37482,0.00262136461222648,0.00236534310156102,-0.00201470786683312,0.00725743709128608,0.267779224793904
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37482,0.00338333984770042,0.00239921937497008,-0.00131913012724093,0.00808580982264177,0.158509343006052
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23536.Triglycerides in Large LDL,37482,-0.00141598135765493,0.0024605672081505,-0.0062386930856299,0.00340673037032005,0.564983756168894
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37482,-0.000732225062480283,0.00232042446849967,-0.00528025702073964,0.00381580689577908,0.752344200767696
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23538.Total Lipids in Medium LDL,37482,0.00137097612977131,0.00233264804463055,-0.00320101403770457,0.00594296629724719,0.556721160953723
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23539.Phospholipids in Medium LDL,37482,0.00209873897417526,0.00231589266268157,-0.00244041064468061,0.00663788859303113,0.36482915568341
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23540.Cholesterol in Medium LDL,37482,0.00129356979966324,0.00233233836130983,-0.00327781338850402,0.0058649529878305,0.579161691618409
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37482,0.000501060833522135,0.00234048699765542,-0.00408629368188248,0.00508841534892675,0.830484897517686
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37482,0.00332807228029249,0.00233362943854297,-0.00124584141925172,0.0079019859798367,0.153853129470314
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23543.Triglycerides in Medium LDL,37482,-0.00168452095043223,0.00249733789611023,-0.00657930322680828,0.00321026132594382,0.499988519296098
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23544.Concentration of Small LDL Particles,37482,9.58640878448573e-05,0.00231464777435613,-0.00444084554989315,0.00463257372558287,0.966964673229858
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23545.Total Lipids in Small LDL,37482,0.00178842149992377,0.00233821598078016,-0.00279448182240535,0.00637132482225289,0.444365296763455
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23546.Phospholipids in Small LDL,37482,0.00252101691489916,0.00232859017617283,-0.00204301983039959,0.0070850536601979,0.278989796223521
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23547.Cholesterol in Small LDL,37482,0.00181485656856938,0.00233056003757702,-0.00275304110508157,0.00638275424222034,0.436158091228493
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37482,0.0010730332518704,0.00234546392478439,-0.00352407604070701,0.0056701425444478,0.647324383467213
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37482,0.00350968465102504,0.00231752401334833,-0.00103266241513769,0.00805203171718776,0.129945799829533
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23550.Triglycerides in Small LDL,37482,-0.00316981650758435,0.00251584372545119,-0.00810087020946869,0.00176123719429999,0.207712946959244
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37482,0.00405448770249257,0.00270617234255486,-0.00124961008891494,0.00935858549390009,0.134095893725108
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37482,0.00411989230760699,0.00272139498423958,-0.00121404186150259,0.00945382647671657,0.130078027557027
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37482,0.00363862090965787,0.00272038193589953,-0.00169332768470522,0.00897056950402095,0.18106962974255
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37482,0.0050200076062795,0.00270653078891382,-0.000284792739991586,0.0103248079525506,0.063650833804992
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37482,0.00558593349556871,0.00275200912684699,0.000191995606948602,0.0109798713841888,0.0424006479845147
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37482,0.00323320489146362,0.00251521480592321,-0.00169661612814587,0.00816302591107312,0.198654866980753
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37482,-0.0030043767280959,0.00243304732411883,-0.00777314948336881,0.00176439602717701,0.216919580354786
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23558.Concentration of Large HDL Particles,37482,0.00565430056031771,0.00287479596672711,1.97004655325787e-05,0.0112889006551028,0.0492213683771161
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23559.Total Lipids in Large HDL,37482,0.00553060217170288,0.00285906960465558,-7.3174253422046e-05,0.0111343785968278,0.0530848182796063
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23560.Phospholipids in Large HDL,37482,0.00500583182489321,0.00282159578169791,-0.000524495907234693,0.0105361595570211,0.0760676869822083
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23561.Cholesterol in Large HDL,37482,0.00644371650685742,0.00286043845104465,0.000837257142809912,0.0120501758709049,0.0242944881601741
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37482,0.00669651425030674,0.00285265788897605,0.00110530478791369,0.0122877237126998,0.0189165341781098
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37482,0.00538707807200966,0.00285463437239711,-0.000208005297888674,0.010982161441908,0.0591644896636318
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23564.Triglycerides in Large HDL,37482,-0.00378679889300276,0.0024004222891459,-0.00849162657972873,0.000918028793723207,0.114692084839626
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37482,0.0040709852453248,0.00256647659030164,-0.000959308871666404,0.00910127936231601,0.112714672242571
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23566.Total Lipids in Medium HDL,37482,0.00355953242543427,0.00254287191432341,-0.00142449652663962,0.00854356137750815,0.161594631955724
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23567.Phospholipids in Medium HDL,37482,0.00272907834049548,0.00252525278601416,-0.00222041712009227,0.00767857380108324,0.279843949953581
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23568.Cholesterol in Medium HDL,37482,0.00544813622131439,0.0025774510702804,0.000396332123564814,0.010499940319064,0.0345539512033572
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37482,0.00561117473120701,0.0025639910118074,0.000585752348064518,0.0106365971143495,0.02865428618728
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37482,0.00453634217332142,0.00261110264177043,-0.00058141900454861,0.00965410335119146,0.0823528909514289
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23571.Triglycerides in Medium HDL,37482,-0.00576209835527042,0.00232093944154183,-0.0103111396606924,-0.00121305704984843,0.0130531229616334
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23572.Concentration of Small HDL Particles,37482,0.00327966828383057,0.00229763058885369,-0.00122368767032267,0.00778302423798381,0.153484785475141
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23573.Total Lipids in Small HDL,37482,0.00183556526064729,0.00232271815926166,-0.00271696233150555,0.00638809285280014,0.429386802425687
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23574.Phospholipids in Small HDL,37482,0.00116948893649211,0.0023473854044303,-0.00343138645619127,0.00577036432917549,0.618345027811254
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23575.Cholesterol in Small HDL,37482,0.00427999972094282,0.00230298764173569,-0.00023385605685913,0.00879385549874477,0.0631269111692192
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37482,0.00447312749265976,0.00227533717268837,1.34666341905657e-05,0.00893278835112896,0.0493292235104981
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37482,0.00290352378049997,0.0023940919556642,-0.00178889645260185,0.0075959440136018,0.225233225237588
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23578.Triglycerides in Small HDL,37482,-0.00571411904663273,0.00239814529564979,-0.0104144838261063,-0.00101375426715914,0.0171993108846754
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-0.00180184751592319,0.00216866657041844,-0.00605243399394334,0.00244873896209696,0.406071646785978
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,0.000472719356182673,0.00226841670918683,-0.00397337739382351,0.00491881610618886,0.83492653512099
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,0.000477586420258326,0.00221368075529253,-0.00386122786011503,0.00481640070063169,0.829191552189994
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-9.34957951225394e-05,0.00230760593323588,-0.00461640342426487,0.00442941183401979,0.967682120534944
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,0.00125991499502288,0.00219612723862738,-0.00304449439268679,0.00556432438273255,0.566182295091146
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37282,-0.00200629923611319,0.00213934888504236,-0.00619942305079623,0.00218682457856984,0.348360565124939
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37282,0.00378388668076651,0.00243608069382142,-0.000990831479123475,0.00855860484065649,0.120383738721254
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37282,0.00396571813167048,0.00244275951941073,-0.000822090526374552,0.00875352678971551,0.104516045051364
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37282,0.00240908330256166,0.00230375359515813,-0.00210627374394828,0.0069244403490716,0.295709607262902
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37282,-0.00327753544378217,0.00233714738925237,-0.00785834432671682,0.00130327343915249,0.160830251269273
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37477,-0.00397020855716392,0.00229962139374114,-0.00847746648889654,0.000537049374568713,0.0842880729251369
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37477,0.000200456899572231,0.00225939970184364,-0.0042279665160413,0.00462888031518576,0.929304761041607
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37477,0.00155505494149322,0.00237025857114527,-0.0030906518579515,0.00620076174093794,0.511790837604974
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37477,-0.00184371315578564,0.00217223693090086,-0.00610129754035132,0.00241387122878005,0.396029082596805
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37477,0.00181131019847891,0.00213220313304521,-0.00236780794228969,0.00599042833924752,0.395617794951742
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37482,0.00335751231166919,0.00238863786838549,-0.00132421791036637,0.00803924253370476,0.159861440075636
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37482,0.0051822193392829,0.00249867528509651,0.000284815780493742,0.0100796228980721,0.0381001385585195
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37482,0.00565164373258744,0.00251953124242451,0.000713362497435394,0.0105899249677395,0.0249049740224409
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37482,0.00382503270195475,0.00244030664193834,-0.000957968316244396,0.00860803372015389,0.117036310905197
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37482,-0.00485153460693201,0.0024795351878419,-0.00971142357510214,8.35436123812396e-06,0.0504122330695898
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37482,0.00631867030600048,0.00243625689568713,0.00154360679045371,0.0110937338215473,0.00950837752950642
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37482,0.0042535850624933,0.00237423975985531,-0.000399924866823104,0.0089070949918097,0.073227207984407
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37482,0.00257592829302527,0.0023079102862191,-0.00194757586796416,0.00709943245401471,0.264387003133572
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37482,0.00616172823601245,0.00244317972248827,0.00137309597993544,0.0109503604920895,0.0116803943127254
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37482,-0.00494981966756176,0.00239585736707986,-0.00964570010703828,-0.000253939228085242,0.0388490528193983
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37482,-0.00574724676740358,0.00244395245290609,-0.0105373935750995,-0.000957099959707651,0.0187066795355357
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37482,0.00470517467800881,0.002534111064739,-0.000261683008879631,0.00967203236489725,0.0633713073199861
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37482,0.00537228170632305,0.00255194256987357,0.000370474269370842,0.0103740891432753,0.0352953054915618
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37482,-0.00028455631204223,0.00246648160164854,-0.00511886025127338,0.00454974762718892,0.908154171206183
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37482,-0.0037553628867135,0.00252751905165353,-0.00870930022795443,0.00119857445452743,0.137358832142627
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37482,-0.00471568745962209,0.00229235989613697,-0.00920871285605054,-0.00022266206319363,0.0396933652884054
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37482,0.00558020182725886,0.00242375640144767,0.000829639280421427,0.0103307643740963,0.0213342376643906
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37482,0.00599300683011268,0.00242162184177958,0.0012466280202247,0.0107393856400007,0.0133440627499288
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37482,0.00173585361323885,0.0024681662624021,-0.00310175226106927,0.00657345948754697,0.481883325221309
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37482,-0.00519683944311629,0.00249721186020888,-0.0100913746891257,-0.00030230419710689,0.0374481987430745
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37482,-0.00052017455955157,0.00228733778077634,-0.00500335660987321,0.00396300749077007,0.820104748473297
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37482,0.00609626889827947,0.00250968546418987,0.00117728538846733,0.0110152524080916,0.0151499201632514
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37482,0.00259576902279801,0.00231186641113907,-0.00193548914303457,0.0071270271886306,0.261542138007931
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37482,0.00499918047295146,0.00249656134455919,0.000105920237615457,0.00989244070828746,0.0452595694727866
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37482,-0.00494054511973042,0.00248744737686482,-0.00981594197838546,-6.51482610753732e-05,0.0470330578500833
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37482,0.00600746581233733,0.00225412571374115,0.00158937941340467,0.01042555221127,0.00770607563391787
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37482,-0.000160765724161989,0.00231806398223933,-0.00470417112935108,0.00438263968102711,0.944709348955817
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37482,-0.00532069343109366,0.0023531442027866,-0.0099328560685554,-0.000708530793631925,0.023769508551965
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37482,0.00754169669073393,0.0025468411370968,0.00254988806202419,0.0125335053194437,0.00306999019533939
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37482,-0.00376100905774187,0.00239959573327873,-0.00846421669496818,0.000942198579484442,0.117056925837527
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37482,0.00217289500644213,0.00229989108299373,-0.00233489151622557,0.00668068152910983,0.344787854936623
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37482,0.00123805235991094,0.00232507395209483,-0.00331909258619493,0.00579519730601682,0.594403568701019
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37482,-0.00294460588697621,0.00232136649532275,-0.0074944842178088,0.00160527244385639,0.204649417049334
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37482,0.00666022099570667,0.00248724921771142,0.00178521252899229,0.011535229462421,0.00742123667012884
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37482,-0.00568941673833581,0.00245557357343132,-0.0105023409422612,-0.000876492534410433,0.0205224231751885
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37480,0.000238567555092315,0.00264582688286615,-0.00494725313532533,0.00542438824550996,0.928155508579228
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37480,0.00346430464360876,0.00264008630002348,-0.00171026450443727,0.00863887379165479,0.189477901292819
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37480,0.00692983622237421,0.00264889043243132,0.00173801097480883,0.0121216614699396,0.00890358277828542
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37480,-0.00430241210109054,0.00282107918149681,-0.00983172729682429,0.00122690309464321,0.127259824131313
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37480,-0.00584387084930532,0.00263798185894744,-0.0110143152928423,-0.000673426405768338,0.0267580170817521
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37482,-0.00541663004662688,0.00274372742112668,-0.0107943357920352,-3.89243012185814e-05,0.0483816092883641
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37482,0.00858061577052164,0.00273570917390452,0.00321862578966878,0.0139426057513745,0.00171344304302704
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37482,0.00838598879726912,0.00276032058453593,0.0029757604515787,0.0137962171429595,0.0023858677307185
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37482,0.0029392549825359,0.00265310927844835,-0.00226083920322286,0.00813934916829466,0.267945770694961
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37482,-0.00823055629607567,0.00265958342763959,-0.0134433398142493,-0.00301777277790208,0.00197443568605223
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37482,-0.00808290682449701,0.00259195224788434,-0.0131631332303503,-0.00300268041864371,0.00182193160870578
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37482,0.00876594588391526,0.0025297847658747,0.00380756774280085,0.0137243240250297,0.000531749251611582
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37482,0.00837546326690893,0.0025097414750483,0.00345636997581426,0.0132945565580036,0.000848694522471527
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37482,0.00608109473287737,0.00273183724225705,0.000726693738053548,0.0114354957277012,0.0260306050003935
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37482,-0.00844863492934166,0.0024607781797969,-0.0132717601617436,-0.00362550969693974,0.000598095924033018
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37482,-0.00433140022080921,0.00239181445665952,-0.00901935655586188,0.000356556114243459,0.0701752473369838
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37482,0.00800019350402942,0.0024004378477577,0.00329533532242432,0.0127050516856345,0.000862143228540528
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37482,0.00676806376384152,0.00240653077487335,0.00205126344508977,0.0114848640825933,0.00492508744894811
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37482,0.00325307061627803,0.00246464164779465,-0.00157762701339948,0.00808376824595553,0.186892935789525
PRAME,Melanoma antigen preferentially expressed in tumors,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37482,-0.0079503933598788,0.00245948075108119,-0.0127709756319979,-0.00312981108775967,0.00122996020553816
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47429,0.0020199427410936,0.00199087979952271,-0.00188218166597091,0.0059220671481581,0.310308157836216
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47429,0.00229170357375762,0.00195088266462484,-0.00153202644890705,0.0061154335964223,0.240126582847722
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45782,0.000315951592046639,0.00186985223755991,-0.00334895879357078,0.00398086197766406,0.865820722097853
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45782,0.00268961639647131,0.0020429257988635,-0.00131451816930115,0.00669375096224377,0.188003253932524
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45782,0.000994229259076392,0.0019967602292047,-0.00291942079016482,0.00490787930831761,0.618544714097915
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45782,-0.000432154019514608,0.00183541664359292,-0.00402957064095673,0.00316526260192751,0.813859556263992
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24009.Traffic intensity on the nearest road,47429,0.257113129882962,0.0992086129180373,0.0626642485636089,0.451562011202315,0.00955797499383018
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24010.Inverse distance to the nearest road,47429,-0.00115985355774764,0.00174838361870298,-0.00458668545040549,0.00226697833491021,0.507089899927209
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24011.Traffic intensity on the nearest major road,47429,-0.00111075852228742,0.00175016440561752,-0.00454108075729777,0.00231956371272292,0.525656811437352
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24012.Inverse distance to the nearest major road,47429,0.00268472190267472,0.0017811785727559,-0.00080638809992685,0.00617583190527628,0.131754510727321
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24013.Total traffic load on major roads,47429,0.135017882605456,0.0715779680632218,-0.00527493479845886,0.275310700009371,0.0592664591385395
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24015.Sum of road length of major roads within 100m,47429,0.0920649482182859,0.0695648781756115,-0.0442822130059125,0.228412109442484,0.185702237800422
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47429,0.00100597039010721,0.00198427769928074,-0.00288321390048305,0.00489515468069747,0.612180335714554
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47429,0.00129877336124296,0.00198036942282538,-0.00258275070749478,0.00518029742998071,0.511944080485364
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47429,0.00106326379455905,0.00196296215326826,-0.00278414202584673,0.00491066961496483,0.588055996373924
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47374,-1.91847759113659e-05,0.00193056045931284,-0.00380308327616453,0.0037647137243418,0.992071308858324
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24020.Average daytime sound level of noise pollution,47429,0.0007392619566056,0.00175925931445186,-0.00270888629972005,0.00418741021293125,0.674334484786714
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24021.Average evening sound level of noise pollution,47429,0.000760464230670863,0.00175926480629514,-0.00268769478966762,0.00420862325100934,0.665554684099543
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24022.Average night-time sound level of noise pollution,47429,0.000737720769882886,0.00175923330077419,-0.00271037649963452,0.00418581803940029,0.674969976916524
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47429,0.000765388514031329,0.00175924263247516,-0.00268272704561999,0.00421350407368264,0.663517840925621
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47429,0.000757817319858384,0.0017593011152098,-0.00269041286595283,0.00420604750566959,0.666654875339261
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44816,-0.00131231986562979,0.00204302155098176,-0.00531664210555404,0.00269200237429446,0.520657962441907
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44816,0.00086432879203321,0.00186160267497145,-0.00278441245091084,0.00451307003497726,0.642442916793757
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24502.Water percentage, buffer 1000m",44816,-0.00309224066857861,0.00182439647185405,-0.00666805775341253,0.000483576416255323,0.0901022884975711
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44816,-0.0006050913507,0.00192555298954676,-0.00437917521021165,0.00316899250881165,0.753339783230233
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44816,0.000378957723812624,0.00187987001469834,-0.00330558750499613,0.00406350295262138,0.840241469886534
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24505.Water percentage, buffer 300m",44816,-0.000455243259338817,0.00184119900505292,-0.00406399330924253,0.0031535067905649,0.804714384087532
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47576,-0.00209702082434105,0.0019494125043509,-0.00591786933286881,0.00172382768418672,0.28206399749833
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47576,-0.00176882579970086,0.00184117914624589,-0.00537753692634281,0.00183988532694109,0.336711712143797
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X24508.Distance (Euclidean) to coast,47576,-0.00400300598939113,0.00175118947903703,-0.00743533736830371,-0.000570674610478542,0.0222703840024144
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,33885,-0.0241307489110965,0.077782099905201,-0.17658366472529,0.128322166903097,0.756388923702567
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2704.Years since last cervical smear test,42153,0.0730104528419082,0.0547187597226424,-0.0342383162144709,0.180259221898287,0.182127442241959
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2714.Age when periods started (menarche),47009,-0.0453038743240692,0.0474426953997121,-0.138291557307505,0.0476838086593664,0.339629500963794
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2734.Number of live births,47715,0.0105479680078549,0.0456581161808213,-0.0789419397065549,0.100037875722265,0.817300786296574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2744.Birth weight of first child,42920,0.0517062449860083,0.0504700787923092,-0.0472151094469178,0.150627599418934,0.305615876938585
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2754.Age at first live birth,40184,0.000610110115978835,0.00222082113515292,-0.00374269930892088,0.00496291954087855,0.783532849724152
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2764.Age at last live birth,40137,0.00446845040834322,0.00213932738976059,0.000275368724412457,0.00866153209227398,0.0367492482954707
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2794.Age started oral contraceptive pill,42253,5.32742330352036e-05,0.00241041944447118,-0.00467114787812831,0.00477769634419871,0.982367122603393
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2804.Age when last used oral contraceptive pill,40591,0.0029952060747722,0.00211217318607388,-0.00114465336993261,0.00713506551947701,0.156190100202977
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2867.Age started smoking in former smokers,29189,-0.0023367428625034,0.00413955714984453,-0.0104502748761987,0.00577678915119187,0.5724467330698
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33584,0.11286256585599,0.0811479613909201,-0.0461874384702131,0.271912570182194,0.164312573223048
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33576,0.0808368701481897,0.0886739163623655,-0.0929640059220467,0.254637746218426,0.3619931502151
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33604,0.0851065177737439,0.0965668099736959,-0.1041644297747,0.274377465322188,0.378166354450457
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33563,0.128157777840706,0.092723193632674,-0.0535796816793354,0.309895237360747,0.166958162344957
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28739.Difficulty with standing for long periods,33619,0.0072832498693711,0.0820466021558671,-0.153528090356128,0.168094590094871,0.929266901421864
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28740.Difficulty with taking care of household responsibilities,33643,-0.0101670917781794,0.0892515381691015,-0.185100106589618,0.164765923033259,0.909307638702043
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28741.Difficulty learning a new task,33547,0.141202064573988,0.0980044056884019,-0.0508865705752794,0.333290699723256,0.149683365978017
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28742.Difficulty with joining in community activities,33312,0.125527107651406,0.103944297184425,-0.0782037148300665,0.329257930132879,0.227218691663161
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28743.Difficulty with being emotionally affected by health problems,33583,0.0403014198923333,0.0877819343653481,-0.131751171463749,0.212354011248416,0.646167286021214
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33634,0.0252298703027042,0.129415946523919,-0.228425384884178,0.278885125489586,0.845435004875315
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29166,0.0109479622114447,0.103088321692014,-0.191105148304902,0.213001072727792,0.91542832580656
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2897.Age stopped smoking,29197,-0.00689382138057926,0.0042437454808493,-0.0152115625230439,0.00142391976188536,0.104342738027894
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32683,-0.00562126961377056,0.00608492932769333,-0.0175477310960495,0.00630519186850837,0.355616516802047
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32683,0.00124124205846647,0.00648526647037723,-0.0114698802234729,0.0139523643404058,0.848221524437402
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32683,0.00978635517009931,0.0216330686821619,-0.032614459446938,0.0521871697871367,0.651007588559803
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32683,0.0476226949926837,0.0231114922364284,0.0023241702092841,0.0929212197760833,0.0393760645644615
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32683,-0.0114638383214808,0.0240233956145357,-0.0585496937259708,0.0356220170830092,0.633236117199518
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32683,0.00311907784270793,0.0195882151115019,-0.0352738237758359,0.0415119794612517,0.873489711387724
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32683,-0.00313130955917302,0.00917747154769119,-0.0211191537926477,0.0148565346743017,0.732965319428601
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32683,0.00317991455785326,0.0159441523780915,-0.0280706241032061,0.0344304532189126,0.841922871629299
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29002.Recent lack of interest or pleasure in doing things,32626,-0.119810180587105,0.0999997967605645,-0.315809782237811,0.0761894210636017,0.23091118424635
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29003.Recent feelings of depression,32613,-0.071164021708344,0.0955615581151932,-0.258464675614123,0.116136632197435,0.456478791012933
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32631,-0.0752756497762402,0.0781806976683059,-0.22850981720612,0.0779585176536394,0.335655352834402
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29005.Recent feelings of tiredness or low energy,32639,-0.0671859759709494,0.0795750505735379,-0.223153075095084,0.0887811231531849,0.398521121255626
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29006.Recent poor appetite or overeating,32646,-0.0192127364880093,0.10266161704761,-0.220429505901325,0.182004032925307,0.851550602243265
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29007.Recent feelings of inadequacy,32603,-0.0838852941055782,0.102873313450919,-0.285516988469379,0.117746400258222,0.414853898053882
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29008.Recent trouble concentrating on things,32645,-0.0662352236270725,0.10431342201939,-0.270689530785076,0.138219083530931,0.52546990565093
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32633,0.0402994566782871,0.186221287787645,-0.324694267385497,0.405293180742071,0.828676466267745
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29010.Recent thoughts of suicide or self-harm,32578,-0.298391988473446,0.213981927342502,-0.71779656606475,0.121012589117857,0.163212992484337
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#0.Substances taken for depression_None of options listed,31793,0.0127426464776524,0.0114378016051154,-0.00967544466837377,0.0351607376236786,0.265280574402547
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31793,0.00399071465994047,0.0227917901007148,-0.0406811939374606,0.0486626232573415,0.861010292599443
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31793,0.0028476941040484,0.010701237910284,-0.0181267322001083,0.0238221204082051,0.790162853379781
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31793,0.00929411659344803,0.0314816657832439,-0.0524099483417099,0.070998181528606,0.767831766238735
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31793,0.0264640509620554,0.019719068074596,-0.0121853224641527,0.0651134243882636,0.179620045699986
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31793,0.011935145339652,0.0205773670736051,-0.0283964941246141,0.0522667848039181,0.561923490476855
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31793,0.0261225207795153,0.024563303396865,-0.0220215538783401,0.0742665954373708,0.287600438753675
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31793,0.00194788509709693,0.0270987236899748,-0.0511656133352537,0.0550613835294475,0.942698517807345
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31793,-0.00703043040957834,0.0205973661992289,-0.0474012681600669,0.0333404073409102,0.732867441587434
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31793,0.00621301424129336,0.0114730941014238,-0.0162742501974973,0.0287002786800841,0.588159384519384
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31793,-0.00383252410290117,0.017494755701516,-0.0381222452778726,0.0304571970720703,0.826603926488801
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31793,0.0770265397316518,0.0269770198602331,0.024151580805595,0.129901498657709,0.00431215273570193
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31793,0.0260866023391287,0.0354085048601038,-0.0433140671866748,0.0954872718649321,0.461308478147018
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31793,0.0102656525090315,0.0238061865176541,-0.0363944730655706,0.0569257780836336,0.666322639830446
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31793,0.0796661517295502,0.0390209990691619,0.00318499355399285,0.156147309905108,0.0412246609146617
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31793,0.092786075813965,0.0363549197630872,0.0215304330783142,0.164041718549616,0.0107236906230997
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31793,0.0375394685358076,0.0198430032314478,-0.00135281779783014,0.0764317548694454,0.0585537632818197
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31793,0.00391055164412869,0.0194225385930395,-0.0341576239982287,0.0419787272864861,0.840437592277623
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31793,-0.00468874960534693,0.0267376652121559,-0.0570945734211725,0.0477170742104787,0.860800646378225
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29058.Recent feelings or nervousness or anxiety,32511,-0.00417554569974624,0.0868523423315128,-0.174406136669511,0.166055045270019,0.961656566785034
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29059.Recent inability to stop or control worrying,32521,-0.133873313639119,0.0903877407595131,-0.311033285527765,0.0432866582495267,0.138618892653908
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29060.Recent worrying too much about different things,32514,-0.00254515553630022,0.0838152918837177,-0.166823127628387,0.161732816555786,0.975775718313107
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29061.Recent trouble relaxing,32522,-0.11729821374753,0.089533764987924,-0.292784393123861,0.0581879656288007,0.190199200074276
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29062.Recent restlessness,32529,0.00210082521665498,0.128565277480129,-0.249887118644397,0.254088769077707,0.986963124534523
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29063.Recent easy annoyance or irritability,32498,0.0297735513658513,0.0931651984166175,-0.152830237530719,0.212377340262422,0.749296523866769
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29064.Recent feelings of foreboding,32490,-0.0468925508361507,0.100664759923718,-0.244195480286639,0.150410378614337,0.641350627113284
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31793,0.0140468877538539,0.0114764877069535,-0.00844702815177488,0.0365408036594826,0.221002461053676
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31793,0.00682145312587144,0.0194069557122574,-0.0312161800701532,0.044859086321896,0.725226908735379
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31793,0.0259674416984834,0.0248297035634095,-0.0226987772857992,0.074633660682766,0.295677814715866
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31793,0.00433893449726287,0.027849844423242,-0.0502467605722915,0.0589246295668172,0.876196971406157
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#2.Symptoms of panic attack_Sweating,31793,-0.0130100114911957,0.0187635339550768,-0.0497865380431463,0.0237665150607549,0.488101328264135
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31793,0.0248982583818518,0.0186074753418293,-0.0115723932881337,0.0613689100518373,0.180912369263742
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31793,0.0362410441764621,0.0190223597838435,-0.00104278099987115,0.0735248693527953,0.0567955424044971
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31793,0.0275489803713621,0.0172771034523429,-0.00631414239522993,0.0614121031379541,0.11085886344505
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31793,-0.00866957284033439,0.0230631432970441,-0.0538733337025409,0.0365341880218721,0.706997677443615
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29076.Felt loved as a child,32493,-0.109706719457295,0.0820713224793262,-0.270566511516774,0.0511530726021844,0.181350525725527
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29077.Physically abused by family as a child,32507,0.142908043850014,0.113081285202771,-0.0787312751474166,0.364547362847444,0.206351374485762
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29078.Felt hated by family member as a child,32487,0.00940958278184418,0.108023711401601,-0.202316891565293,0.221136057128981,0.930588917098624
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29079.Sexually molested as a child,32405,0.136489307150641,0.132806140155577,-0.12381072755429,0.396789341855571,0.304106515411146
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29080.Someone to take to doctor when needed as a child,32471,0.12013613399252,0.117156032363103,-0.109489689439163,0.349761957424202,0.305187965502007
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32485,-0.0310068765593303,0.145533679179702,-0.316252887751546,0.254239134632885,0.831288406609057
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32422,-0.0573884476325369,0.108471033385769,-0.269991673068644,0.15521477780357,0.59677368669354
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32487,-0.135983305120398,0.123030479180736,-0.377123044314641,0.105156434073844,0.269070756039559
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32450,-0.10611398432503,0.154221486115291,-0.408388097111002,0.196160128460941,0.491433532026599
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32456,-0.0460348336479411,0.15138042225549,-0.342740461268702,0.25067079397282,0.761059375304888
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29086.Experienced a violent or sexual assault,32486,-0.0998397954808484,0.142335010124815,-0.378816415325486,0.179136824363789,0.483047357430925
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29087.Experienced a life-threatening injury or illness,32497,0.0670972612700596,0.0983201661069108,-0.125610264299486,0.259804786839605,0.494982689739612
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29088.Experienced a marital separation or divorce,32499,-0.0665412740203865,0.0889059054207418,-0.24079684864504,0.107714300604267,0.454213029782335
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29089.Experienced the death of a spouse or partner,32506,0.0416620189625884,0.112091261347547,-0.178036853278603,0.26136089120378,0.710141301944697
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32495,0.188038240962161,0.109528923592104,-0.0266384492783625,0.402714931202685,0.0860559207277313
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29091.Frequency of drinking alcohol,32503,0.0631831168888973,0.0743363251607008,-0.0825160804260762,0.208882314203871,0.395371009311263
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31451,0.0257821446442708,0.0934644179887241,-0.157408114613628,0.20897240390217,0.782671549735731
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31463,0.023706926047173,0.0947526926465598,-0.162008351540084,0.20942220363443,0.802441632291703
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29104.Ever used cannabis,32497,0.0459512968631512,0.114715432267762,-0.178890950381662,0.270793544107964,0.688749071020155
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29108.Ever thought that life not worth living,32454,0.0555475658562762,0.0883882709445807,-0.117693445195102,0.228788576907654,0.529727448878354
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29109.Ever contemplated self-harm,32480,0.0450400632753702,0.119033621714166,-0.188265835284396,0.278345961835136,0.705157571549712
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29111.Ever self-harmed,32495,0.159117102261698,0.182489809657617,-0.198562924667231,0.516797129190627,0.383276295676639
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32487,-0.0355222356301987,0.126836854250017,-0.284122469960232,0.213077998699835,0.779436830605931
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32369,0.0109894308868879,0.0241457236431601,-0.0363361874537059,0.0583150492274818,0.649028563614228
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32369,-0.00861217246763262,0.0193115035457292,-0.0464627194172619,0.0292383744819967,0.655637798879051
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32369,-0.00635621194988063,0.0195362637718721,-0.04464728894275,0.0319348650429887,0.744921361209207
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32369,0.0107022358047148,0.0250822439057035,-0.038458962250464,0.0598634338598937,0.669619840090731
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32481,0.0989146127682302,0.0822477794238623,-0.06229103490254,0.260120260439,0.229150455457891
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X29153.Pain or discomfort today,32493,-0.0881388941270213,0.0786780700957041,-0.242347911514601,0.0660701232605587,0.262641870915103
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29154.Anxiety or depression today,32493,-0.0294967545670426,0.0949105223427662,-0.215521378358864,0.156527869224779,0.755972229248246
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29166.Frequency of confiding in someone close,32291,-0.0193728150269668,0.0769060925515719,-0.170108756428048,0.131363126374114,0.8011232548258
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32464,0.00476835281647196,0.00652723506171171,-0.00802502790448299,0.0175617335374269,0.465086539531577
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32464,0.00527093298755638,0.00640700260555496,-0.00728679211933134,0.0178286580944441,0.410712692216243
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32464,-0.00893467594573018,0.00940269604779022,-0.027363960199399,0.00949460830793865,0.342026649224907
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32464,-0.0143004644856699,0.00814159666896092,-0.0302579939568333,0.00165706498549349,0.079046510558298
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32464,-0.00773644068598971,0.0119405770322775,-0.0311399716692535,0.0156670902972741,0.517060567912298
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32464,-0.00419248609478427,0.00637811835478153,-0.0166935980701561,0.00830862588058754,0.51099191060525
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32463,-0.000219215694605676,0.00706545406874307,-0.0140675056693421,0.0136290742801307,0.975249248341947
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32463,0.000379174984673106,0.00989767358448796,-0.0190202652409233,0.0197786152102695,0.969441866309461
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32463,-0.0145247199292455,0.021094026585471,-0.0558690120367688,0.0268195721782777,0.491113664398756
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32463,-0.0146205941487149,0.0135469911081932,-0.0411726967207735,0.0119315084233438,0.28050865699865
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32463,-0.0113450354635642,0.018859894048899,-0.0483104277994062,0.0256203568722777,0.547495465378794
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32463,0.00426536622385744,0.0100308551111384,-0.0153951097939738,0.0239258422416886,0.670684383620351
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29171.Frequency of feeling 'in tune' with people,32370,0.123862508360791,0.0973240636314867,-0.0668926563569232,0.314617673078505,0.2031685565246
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29172.Freuency of feeling that lacks companionship,32444,-0.0465930160361512,0.0864571620152377,-0.216049053586017,0.122863021513715,0.589960881874785
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29173.Frequency of feeling left out,32391,-0.0078633287193769,0.0893069883953802,-0.182905025974322,0.167178368535568,0.929840506460311
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29174.Frequency of feeling isolated from others,32417,-0.0460261587820553,0.093058350212865,-0.228420525199271,0.13636820763516,0.620899947967139
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29175.Tendency to bounce back quickly after hard times,32481,0.122892137625543,0.0768533067502132,-0.0277403436048747,0.273524618855961,0.109849267326858
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29176.Ability to make it through stressful events,32481,-0.133942091087903,0.0751600359485086,-0.281255761546979,0.0133715793711743,0.0747720416975841
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29177.Quick recovery from stressful events,32481,0.0846594238947015,0.0763151765829474,-0.0649183222078754,0.234237169997278,0.267317078786876
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29178.Hard to snap back when something bad happens,32481,-0.179160180495398,0.0756773596693603,-0.327487805447344,-0.0308325555434515,0.0179361183233598
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29179.Comes through difficult times with little trouble,32481,0.124977011405445,0.0758303995694726,-0.0236505717507215,0.273604594561611,0.0993687780669658
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29180.Tendency to take a long time to get over setbacks,32481,-0.190809232655024,0.0760993184285938,-0.339963896775068,-0.0416545685349806,0.0121828858048606
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29181.General happiness,32434,-0.0953920130041208,0.0794490931594158,-0.251112235596576,0.0603282095883342,0.229915516652013
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,X29182.Belief that own life is meaningful,32346,0.0696039743295301,0.0789273013398954,-0.0850935362966648,0.224301484955725,0.377871539916138
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28809,-0.107865924672636,0.102303222545191,-0.30838024086121,0.0926483915159385,0.291769900483527
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2946.Father's age,29651,0.00226263692846045,0.00592199872735608,-0.00934448057715747,0.0138697544340784,0.702422695447989
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X2966.Age high blood pressure diagnosed,29413,-0.00370433555097016,0.00437827828731308,-0.0122857609941038,0.00487708989216347,0.397553783475591
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30000.White blood cell (leukocyte) count,46960,-0.00215370963049367,0.00184901439452554,-0.00577777784376373,0.00147035858277639,0.244117194694331
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46960,-0.00498335547624653,0.00218051729194238,-0.00925716936845359,-0.000709541584039477,0.0222986049696019
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30020.Haemoglobin concentration,46960,-0.00725694380934456,0.00237215220808373,-0.0119063621371887,-0.00260752548150045,0.00222172348745572
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30030.Haematocrit percentage,46960,-0.00719515912520291,0.00230163733277314,-0.0117063682974383,-0.00268394995296756,0.00177363908604968
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30040.Mean corpuscular volume,46960,-0.00120389771405162,0.0018200942984861,-0.00477128253908437,0.00236348711098113,0.508331829673799
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46959,-0.000789335019845676,0.00182705271991286,-0.00437035835087488,0.00279168831118353,0.665726360185136
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46959,0.000807359755317778,0.00178826885628113,-0.00269764720299324,0.0043123667136288,0.651651156865304
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46960,0.000449964806782629,0.00172298045993341,-0.00292707689468685,0.00382700650825211,0.793975437810277
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30080.Platelet count,46960,-0.000429144913766087,0.00182839842511446,-0.00401280582699042,0.00315451599945824,0.814435315634928
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30090.Platelet crit,46960,0.000948738355285664,0.00187563268158368,-0.00272750170061835,0.00462497841118968,0.612985787499777
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46960,0.00170132162693313,0.00176521438527517,-0.00175849856820621,0.00516114182207247,0.335154287915819
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30110.Platelet distribution width,46960,0.00133925024165552,0.00176680081748914,-0.0021236793606232,0.00480217984393424,0.448453761156751
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30120.Lymphocyte count,46928,0.000161984586686071,0.0018364170232354,-0.00343739277885531,0.00376136195222746,0.929713047716881
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30130.Monocyte count,46928,-0.00150784651116661,0.00186618839608335,-0.00516557576748997,0.00214988274515675,0.419109532917347
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30140.Neutrophill count,46928,-0.00320718297292011,0.00183757573572701,-0.00680883141494505,0.000394465469104829,0.0809404533252244
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30150.Eosinophill count,46928,0.00122455788175204,0.00180813611202442,-0.00231938889781582,0.0047685046613199,0.498255126264443
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30160.Basophill count,46928,-0.00564222712657435,0.0517185640272857,-0.107010612620054,0.0957261583669056,0.913128262060227
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30170.Nucleated red blood cell count,46928,-0.234792641200181,0.231580133443579,-0.688689702749596,0.219104420349234,0.310654689984888
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30180.Lymphocyte percentage,46928,0.00232374853061588,0.00181454576817793,-0.00123276117501287,0.00588025823624463,0.20033943181422
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30190.Monocyte percentage,46928,0.000543170789599517,0.00184441614790645,-0.00307188486029712,0.00415822643949616,0.768382628547538
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30200.Neutrophill percentage,46928,-0.00294440540783968,0.00179874135389797,-0.0064699384614797,0.000581127645800351,0.101660058231373
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30210.Eosinophill percentage,46928,0.0021727136230695,0.00178705554364606,-0.00132991524247677,0.00567534248861578,0.224071437698542
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30220.Basophill percentage,46928,0.00331482440527317,0.0017140478936572,-4.47094662949453e-05,0.00667435827684129,0.0531360124568058
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30230.Nucleated red blood cell percentage,46928,-0.242215838948674,0.231509644197425,-0.695974741575627,0.211543063678279,0.295459120887531
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30240.Reticulocyte percentage,46534,-0.00219354949163721,0.0018849132920643,-0.00588797954408324,0.00150088056080881,0.244541860999867
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30250.Reticulocyte count,46534,-0.00322890849996951,0.00194814737570873,-0.00704727735635862,0.000589460356419602,0.0974477508820991
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30260.Mean reticulocyte volume,46534,-0.000407178054947482,0.00179903466956974,-0.00393328600730418,0.00311892989740922,0.820945764698013
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30270.Mean sphered cell volume,46534,-0.000661128049517491,0.00181863560511189,-0.0042256538355368,0.00290339773650182,0.71621271355292
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30280.Immature reticulocyte fraction,46534,-0.00270280533651245,0.00190521451786101,-0.00643702579152004,0.00103141511849514,0.156019364542443
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46534,-0.00263001189477933,0.00193642664961301,-0.00642540812802083,0.00116538433846217,0.174421114947849
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30300.High light scatter reticulocyte count,46534,-0.00364898976163044,0.00198568269233324,-0.00754092783860358,0.000242948315342711,0.0661274259444237
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30500.Microalbumin in urine,30961,-0.00302488533362923,0.00339625341383169,-0.00968154202473934,0.00363177135748087,0.373147952987674
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47015,-0.000579881253334967,0.00188854276333901,-0.00428142506947943,0.0031216625628095,0.758806456466048
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30520.Potassium in urine,46971,0.00113459708070002,0.00175994286784374,-0.0023148909402737,0.00458408510167374,0.519142210067294
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30530.Sodium in urine,46946,0.00110580665316369,0.00185476552678626,-0.00252953377933738,0.00474114708566477,0.551049264929063
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30600.Albumin,44608,0.00107822944363398,0.00193645217477232,-0.00271721681891977,0.00487367570618774,0.577665723618743
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30610.Alkaline phosphatase,46605,-0.00397059240429723,0.00183351214154622,-0.00756427620172782,-0.000376908606866646,0.0303549673203974
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30620.Alanine aminotransferase,46613,-0.00411082431005916,0.00191320495275497,-0.00786070601745889,-0.000360942602659419,0.031672271924257
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30630.Apolipoprotein A,44412,0.00192117738519107,0.00213365897366489,-0.00226079420319213,0.00610314897357426,0.367910593629044
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30640.Apolipoprotein B,46511,0.00226694484544166,0.00182649130044656,-0.00131297810343359,0.00584686779431691,0.214564517086078
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30650.Aspartate aminotransferase,46547,-0.00186169789236585,0.00183659163608325,-0.00546141749908901,0.00173802171435731,0.310751330934065
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30660.Direct bilirubin,41671,-0.00472010412149843,0.00206566685739994,-0.00876881116200231,-0.000671397080994549,0.022323359256788
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30670.Urea,46604,-0.00134316497502038,0.00191747822368107,-0.00510142229343528,0.00241509234339452,0.48363174785682
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30680.Calcium,44611,-0.000884549120046398,0.00186120811661051,-0.00453251702860299,0.0027634187885102,0.634610126971525
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30690.Cholesterol,46614,0.00264255679195296,0.0018788310208137,-0.00103995200884188,0.00632506559274781,0.159592733074874
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30700.Creatinine,46608,1.34125281232485e-05,0.00212335838024582,-0.00414836989715855,0.00417519495340505,0.994960126708015
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30710.C-reactive protein,46556,-0.00606733155772702,0.00199949335809313,-0.00998633853958956,-0.00214832457586449,0.00241267074494977
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30720.Cystatin C,46611,-0.00327061065996627,0.00207003160686648,-0.00732787260942457,0.000786651289492043,0.114125485130478
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30730.Gamma glutamyltransferase,46611,-0.000772801581432296,0.00188392841736621,-0.00446530127947007,0.00291969811660548,0.68165769956037
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30740.Glucose,44587,0.00147770993048828,0.00200993844978326,-0.00246176943108691,0.00541718929206347,0.462225297948702
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46528,0.00268890162756362,0.00205641348745976,-0.00134166880785752,0.00671947206298475,0.191033302721374
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30760.HDL cholesterol,44598,0.00307252842398678,0.0022368479549466,-0.00131169356770856,0.00745675041568212,0.169582004457978
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30770.IGF-1,46487,-0.00149350181114713,0.00183718902709271,-0.00509439230424884,0.00210738868195458,0.416268307106101
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30780.LDL direct,46564,0.00184997767054927,0.00183029972419038,-0.00173740978886387,0.00543736512996242,0.312146577531392
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30790.Lipoprotein A,42193,-0.00159894881741248,0.00200494646521214,-0.00552864388922828,0.00233074625440331,0.42517021482075
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30810.Phosphate,44571,-6.07256911905069e-06,0.00200225565421662,-0.00393049365138363,0.00391834851314553,0.997580158408043
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30830.SHBG,44383,-0.000237100561921519,0.00210464333395787,-0.00436220149647894,0.0038880003726359,0.910304472362998
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30840.Total bilirubin,46532,-0.00318601299812578,0.00183830781835568,-0.00678909632210291,0.000417070325851364,0.0830878248496909
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30850.Testosterone,42789,0.000286250609344569,0.00325619894158363,-0.00609589931615935,0.00666840053484849,0.92994961751151
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30860.Total protein,44606,-0.00223685046203161,0.00189875065974926,-0.00595840175514017,0.00148470083107695,0.238784862875342
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30870.Triglycerides,46606,-0.00157666668636626,0.00203025089540369,-0.0055559584413575,0.00240262506862498,0.437410696803002
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30880.Urate,46585,-0.0012297242381652,0.00225576646058659,-0.00565102650091492,0.00319157802458452,0.585657937451929
PRAME,Melanoma antigen preferentially expressed in tumors,Blood and urine assays,X30890.Vitamin D,45316,0.00071946428658769,0.00200794365299837,-0.00321610527328912,0.0046550338464645,0.720115707109131
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3137.Number of measurements made,45679,-0.037743362975455,0.0569527508327117,-0.14937075460757,0.07388402865666,0.507521188812836
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3143.Ankle spacing width,37599,0.00603424806368785,0.00315003545278895,-0.000139821423778496,0.0122083175511542,0.0554360735418338
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37598,-0.000941423877627579,0.00255446702212079,-0.00594817924098433,0.00406533148572917,0.712476383994078
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3146.Speed of sound through heel,37599,-0.00107916289032381,0.00246171406051551,-0.00590412244893422,0.00374579666828659,0.661119022348303
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37599,-0.000975865285578839,0.00249346599928079,-0.00586305864416918,0.00391132807301151,0.695530848344426
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X3148.Heel bone mineral density (BMD),37597,-0.0011076820732057,0.00248724332542871,-0.00598267899104597,0.00376731484463457,0.656077584363418
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3526.Mother's age at death,38298,0.000272146614647232,0.00232862633817186,-0.00429196100816961,0.00483625423746408,0.906964748230616
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X3581.Age at menopause (last menstrual period),37775,-0.00141661317738076,0.00233605723678861,-0.00599528536148644,0.00316205900672491,0.544251523731825
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29250,0.00567820540269528,0.00391908924164195,-0.00200320951092294,0.0133596203163135,0.14744247740355
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4100.Ankle spacing width (left),32004,0.00381974123316887,0.00424323099510439,-0.00449699151723573,0.0121364739835735,0.368044449582977
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32004,-0.00259186419969657,0.0034445075653928,-0.00934309902786646,0.00415937062847332,0.451796176823752
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4103.Speed of sound through heel (left),32004,-0.00076427213557608,0.00336263813266331,-0.00735504287559616,0.005826498604444,0.82020946134375
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32004,-0.00131059178778509,0.00338879883225789,-0.00795263749901055,0.00533145392344037,0.698957908471383
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4105.Heel bone mineral density (BMD) (left),32002,-0.00145998477930616,0.00338019906962024,-0.00808517495576182,0.0051652053971495,0.66580991473899
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32004,-0.00130509459699971,0.00338856530808221,-0.00794668260084083,0.00533649340684142,0.700139609350579
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4119.Ankle spacing width (right),32000,0.00691096337009742,0.00419271618132665,-0.00130676034530281,0.0151286870854977,0.0993273975764428
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32000,-0.00246457671750563,0.00344878175112228,-0.0092241889497053,0.00429503551469404,0.474864495118105
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4122.Speed of sound through heel (right),32000,-0.00107280934010563,0.00337698562484542,-0.00769170116480266,0.0055460824845914,0.750734551317193
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32000,-0.0014182131411273,0.00339723574048255,-0.00807679519247309,0.0052403689102185,0.676353180522871
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4124.Heel bone mineral density (BMD) (right),31997,-0.0013415876779493,0.00339231618759909,-0.00799052740564352,0.00530735204974491,0.692501062295333
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32000,-0.00141971426304383,0.00339723818140319,-0.00807830109859409,0.00523887257250643,0.676030306517225
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4194.Pulse rate,32244,0.0054609273019364,0.00332136362248018,-0.00104894539812476,0.0119708000019976,0.100178891610685
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4195.Pulse wave reflection index,32244,-0.00287921732164844,0.00328544797567085,-0.00931869535396331,0.00356026071066643,0.380864327222861
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4196.Pulse wave peak to peak time,32242,8.15086750264063e-05,0.0029998357738992,-0.00579816944181602,0.00596118679186884,0.978324005317313
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4198.Position of the pulse wave peak,32244,0.000327918845462899,0.00291125577310889,-0.00537814246983052,0.00603398016075632,0.910320235967571
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4199.Position of pulse wave notch,32244,0.000886112851340418,0.00324549926787445,-0.00547506571369351,0.00724729141637434,0.784838767183447
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4200.Position of the shoulder on the pulse waveform,32244,-0.000625288382498249,0.00290524651014711,-0.00631957154238658,0.00506899477739008,0.829595734730964
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4269.Number of triplets attempted (left),32152,-0.388098379378815,0.219438706018699,-0.818198243175464,0.0420014844178345,0.0770010051165328
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4270.Volume level set by participant (left),32075,0.0727437539143985,0.0785435239661727,-0.0812015530592999,0.226689060888097,0.354392936536623
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4276.Number of triplets attempted (right),32153,0.164202789828563,0.252592305879272,-0.330878129694811,0.659283709351937,0.515666150114192
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X4277.Volume level set by participant (right),32066,0.0675000708720927,0.0773711911398715,-0.0841474637620555,0.219147605506241,0.383007545593339
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4288.Time to answer,32299,-0.00497996267060407,0.00372983482426331,-0.0122904389261602,0.00233051358495201,0.18185952236372
PRAME,Melanoma antigen preferentially expressed in tumors,Cognitive function,X4290.Duration screen displayed,32299,-0.00288406516943889,0.00326938297038169,-0.009292055791387,0.00352392545250923,0.377726193377867
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X46.Hand grip strength (left),47649,0.00695146132623322,0.00266468163518031,0.00172868532127982,0.0121742373311866,0.00909345675802664
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X47.Hand grip strength (right),47651,0.00466684405826224,0.00266316272459682,-0.000552954881947529,0.00988664299847201,0.0797235716766554
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X48.Waist circumference,47724,-0.00156682787772019,0.00354647475286069,-0.00851791839332714,0.00538426263788675,0.658638996204172
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X4803.Tinnitus,32151,-0.100468326312541,0.0963491713591884,-0.28931270217655,0.0883760495514687,0.297095752169699
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4825.Noisy workplace,32277,0.16044982540413,0.131041035609626,-0.096390604390737,0.417290255198996,0.22082908571801
PRAME,Melanoma antigen preferentially expressed in tumors,Working and living environment,X4836.Loud music exposure frequency,32225,-0.0600081831299956,0.156379400255831,-0.366511807631425,0.246495441371434,0.701185679749915
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X49.Hip circumference,47722,-0.00193613442631114,0.00301372719286881,-0.007843039724334,0.00397077087171173,0.520594827318029
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X50.Standing height,47718,0.00277501739343347,0.00246469697657008,-0.00205578868064389,0.00760582346751083,0.260216874993753
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X5057.Number of older siblings,31372,-0.0866730750789648,0.0840343466464081,-0.251380394505925,0.0780342443479951,0.302389053023603
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,X51.Seated height,47614,0.00245017543466333,0.00247630538853559,-0.00240338312686643,0.00730373399619309,0.322454331589257
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5181.Ever had eye surgery,29752,0.00216277472343516,0.191987003413458,-0.374131751966942,0.378457301413812,0.991012273751853
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5186.Duration visual-acuity screen displayed (right),29738,0.00473770307981337,0.0037873366237682,-0.0026854767027723,0.012160882862399,0.211014410310672
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5188.Duration visual-acuity screen displayed (left),29739,0.00589799495271408,0.00376800165488529,-0.00148728829086109,0.0132832781962893,0.11757604095592
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5190.Duration at which refractometer first shown (right),29674,0.00510578850827242,0.00379476974272592,-0.00233196018747039,0.0125435372040152,0.178528548261464
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5193.Duration at which refractometer first shown (left),29674,0.00240589790212157,0.00382014934639032,-0.00508159481680345,0.00989339062104659,0.528858507407907
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5199.logMAR, initial (right)",29720,0.0593114728210938,0.098283252694618,-0.133323702460357,0.251946648102545,0.546218817272458
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5200.Final number of letters displayed (right),29720,-0.490391077395035,0.610351902923579,-1.68668080712525,0.70589865233518,0.421747313266563
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5201.logMAR, final (right)",29677,0.0021858592117786,0.00393910333365436,-0.00553478332218394,0.00990650174574113,0.578977998536626
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5202.Number of rounds to result (right),29720,0.0204458716243342,0.0941286346744119,-0.164046252337513,0.204937995586182,0.828051540820859
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5206.logMAR, initial (left)",29719,-0.088755816841314,0.100025129255875,-0.28480507018283,0.107293436500202,0.374938989812737
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5207.Final number of letters displayed (left),29719,-0.440038423412874,0.495980590829892,-1.41216038143946,0.532083534613714,0.375006935089882
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5208.logMAR, final (left)",29666,-0.00603281766718443,0.00388922813482748,-0.0136557048114463,0.00159006947707742,0.120923880003409
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5209.Number of rounds to result (left),29717,0.0954353210198779,0.0946967043622664,-0.0901702195301643,0.28104086156992,0.313596985491421
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29474,0.00328062943107116,0.00377149229390409,-0.00411149546498085,0.0106727543271232,0.384424410745587
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29474,-0.0023960252776891,0.00378171997445782,-0.00980819642762643,0.00501614587224823,0.526383268175875
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5256.Corneal hysteresis (right),29474,-0.00756522819263656,0.0037439041748342,-0.0149032803753116,-0.00022717600996153,0.043365985435949
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5257.Corneal resistance factor (right),29474,-0.00679595208444883,0.00373471981578424,-0.0141160029233859,0.000524098754488268,0.0688690094918922
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29466,-0.00275348499825984,0.00380677501176342,-0.0102147640213161,0.00470779402479647,0.469522131521707
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29466,-0.00818475161889477,0.00376620375021708,-0.0155665109693202,-0.000802992268469296,0.0298111757634619
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5264.Corneal hysteresis (left),29466,-0.0063851143621212,0.00386304636352972,-0.0139566852346395,0.00118645651039706,0.0984198826610024
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X5265.Corneal resistance factor (left),29466,-0.00923174417563993,0.00380588453096,-0.0166912778563215,-0.00177221049495834,0.0153160609668238
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29088,1.31973406401835,0.352035880506926,0.629743738224778,2.00972438981193,0.000179803149713932
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47648,0.000855886811231788,0.0102955476996539,-0.0193233866800898,0.0210351603025534,0.933747504360541
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47648,0.00517332872000465,0.0106396116096983,-0.015680310035004,0.0260269674750133,0.626806673403917
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47648,0.0195723657598198,0.0274761887700961,-0.0342809642295687,0.0734256957492083,0.476261932914673
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47648,-0.00200428095778084,0.00450501749345997,-0.0108341152449624,0.0068255533294007,0.656396386457596
PRAME,Melanoma antigen preferentially expressed in tumors,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47648,-0.00132803262843431,0.00412080330136862,-0.0094048070991168,0.00674874184224819,0.747247138263444
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35157,0.0012166302270678,0.00516075052082003,-0.00889844079373946,0.011331701247875,0.813633690975776
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35157,-0.019939693398061,0.0127586256899671,-0.0449465997503965,0.0050672129542745,0.118119740495682
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35157,0.00594714904899143,0.010081554401283,-0.0138126975775233,0.0257069956755062,0.555267477364895
PRAME,Melanoma antigen preferentially expressed in tumors,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35157,0.00381990414036334,0.00621014167319217,-0.00835197353909331,0.01599178181982,0.538496865867645
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47714,0.00447832547353671,0.00838374382523805,-0.0119538124239299,0.0209104633710033,0.593230592546446
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47714,0.00447832547353671,0.00838374382523805,-0.0119538124239299,0.0209104633710033,0.593230592546446
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47714,-0.00338310768763362,0.00681036122714288,-0.0167314156928337,0.00996520031756642,0.619363761783443
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47714,-0.0105358106479529,0.0105059603460984,-0.0311274929263058,0.0100558716304,0.315947882833598
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47714,-0.0225201588712952,0.0265438994138982,-0.0745462017225357,0.0295058839799454,0.396217374112257
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47714,-0.018376146215727,0.0181005372655067,-0.0538531992561202,0.0171009068246662,0.310008400784594
PRAME,Melanoma antigen preferentially expressed in tumors,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47714,0.0448244924193574,0.028945107439907,-0.0119079181628603,0.101556903001575,0.121490686685253
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47648,0.00232686737750748,0.00548026635516544,-0.00841445467861678,0.0130681894336317,0.671139377614749
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47648,0.00922646321487004,0.00914170495063407,-0.00869127848837274,0.0271442049181128,0.312854922460966
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47648,0.00211896603238079,0.00485875893088529,-0.00740420147215438,0.011642133536916,0.662759088125086
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47648,0.0105114693750523,0.00894423331814852,-0.00701922792851883,0.0280421666786233,0.239917544224694
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47648,-0.0130178869527198,0.00869588712921091,-0.0300618257259732,0.00402605182053354,0.134402557865124
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47648,0.00203490079338687,0.00489679355229897,-0.00756281456911912,0.0116326161558929,0.677737450173763
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30652,-0.0191862201987349,0.0188328132327801,-0.0560985341349838,0.0177260937375141,0.308354064206944
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30652,0.00199522679456747,0.0122836224548084,-0.022080673216857,0.0260711268059919,0.870972669484065
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30652,0.0293909160195776,0.0154959774319485,-0.000981199747041486,0.0597630317861968,0.0579165728773574
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30652,-0.0205696948142773,0.0138882854600511,-0.0477907343159775,0.00665134468742288,0.138635439693591
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47640,-0.0131713882226618,0.0132641852588562,-0.03916919133002,0.0128264148846964,0.320718396213139
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47640,0.0278318795298905,0.0237588988007527,-0.0187355621195847,0.0743993211793658,0.241438139478562
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47640,0.0101830636058799,0.0377332377618067,-0.0637740824072612,0.084140209619021,0.787262776591452
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47640,0.0526433587830822,0.0359238542929293,-0.0177673956310593,0.123054113197224,0.142821257016272
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47640,-0.00356268406452543,0.011244155415017,-0.0256012286779587,0.0184758605489079,0.75136206892048
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47640,-0.0121148603411945,0.0159814767123496,-0.0434385546973998,0.0192088340150108,0.448424936968935
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47640,0.000132385756058256,0.00788526680965512,-0.0153227371908658,0.0155875087029823,0.986605088661783
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32439,0.012176057162731,0.011781115177588,-0.0109149285853415,0.0352670429108035,0.301390359783331
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32439,0.0092776419483329,0.0135349852156892,-0.0172509290744179,0.0358062129710837,0.49307587162793
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32439,-0.0190534246519078,0.0176973206493724,-0.0537401731246778,0.0156333238208621,0.281679166794696
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32439,0.00120132136689357,0.00614708611158842,-0.0108469674118197,0.0132496101456069,0.845061771592669
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35366,-0.00741609971675116,0.00614670056693299,-0.0194636328279398,0.00463143339443751,0.227644297595175
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35366,-0.00499792085151123,0.00536610147443412,-0.0155154797414021,0.00551963803837965,0.351673658406506
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35366,0.00602708478242363,0.00504340263528994,-0.00385798438274467,0.0159121539475919,0.232096060667486
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35366,0.00939543645535074,0.0120082396766461,-0.0141407133108756,0.0329315862215771,0.433987225979387
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35366,0.00875320799788843,0.00719557316860705,-0.00535011541258139,0.0228565314083582,0.223831757543096
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35366,0.000796809791968061,0.00845961292696279,-0.015784031544879,0.0173776511288151,0.924960065290328
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47648,0.000549992310463698,0.0119913979223759,-0.0229531476173932,0.0240531322383206,0.963417790628304
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47648,0.00858789027237028,0.00763650560971498,-0.00637966072267108,0.0235554412674116,0.260777091107701
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47648,0.0404585881509841,0.0307870136181562,-0.019883958540602,0.10080113484257,0.188810537752341
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47648,4.04791522487708e-05,0.00755005828275347,-0.014757635081948,0.0148385933864456,0.995722259806032
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47648,0.00622033144577781,0.0089873093679034,-0.0113947949153129,0.0238354578068685,0.488866463205221
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47648,-0.0178872515687085,0.01010347734869,-0.0376900671721409,0.00191556403472386,0.076672751204503
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47648,-0.00466017415201105,0.00361342460176245,-0.0117424863714654,0.00242213806744334,0.197173422891427
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28106,0.00088184534716442,0.0126908685440974,-0.0239922569992665,0.0257559476935954,0.944606097165575
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28106,-0.00260122367768324,0.0170997365348947,-0.0361167072860768,0.0309142599307103,0.879100143905722
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28106,0.0102615496615759,0.0112402373025017,-0.0117693154513274,0.0322924147744792,0.361339579556975
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28106,-0.00359133950540783,0.0100892258397105,-0.0233662221512404,0.0161835431404247,0.721892647351567
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47750,-0.00320569094219192,0.00411550848433044,-0.0112720875714796,0.00486070568709574,0.436029159979826
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47750,-0.00952213070919721,0.0111105349932745,-0.0312987792960152,0.0122545178776207,0.391433693074177
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47750,-0.00891142782149698,0.00402336248816983,-0.0167972182983098,-0.00102563734468413,0.0267751624047706
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47750,-0.0012310309419761,0.00400762946956402,-0.00908598470232158,0.00662392281836939,0.758715319390869
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47750,0.0112261411757648,0.00578290335761325,-0.000108349405157205,0.0225606317566867,0.0522383256458069
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47750,-0.00216547423510681,0.00511327044082529,-0.0121874842991244,0.00785653582891075,0.671933808314541
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47750,0.000536967814215046,0.00429276263107828,-0.00787684694269837,0.00895078257112846,0.900455935846596
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47750,0.00236267280721668,0.0115629049829618,-0.0203006209593884,0.0250259665738217,0.838095761609396
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40522,0.00837838098283066,0.00436989257393244,-0.00018660846207692,0.0169433704277382,0.0552179473670276
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40522,0.00243203620414236,0.00483448748690529,-0.007043559270192,0.0119076316784767,0.614929138699719
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40522,-0.00766253935063896,0.00485126781178246,-0.0171710242617326,0.00184594556045467,0.114242900890046
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40522,0.00140789565537823,0.0061590047649646,-0.0106637536839524,0.0134795449947088,0.819189401225664
PRAME,Melanoma antigen preferentially expressed in tumors,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40522,-0.0100885372437417,0.00440029382214688,-0.0187131131351496,-0.00146396135233379,0.0218783546799004
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47548,-0.0056552125127147,0.00433714933952333,-0.0141560252181804,0.00284560019275103,0.192280401307222
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47548,0.0026169993100418,0.00350544011332422,-0.00425366331207367,0.00948766193215728,0.455340600303354
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47548,0.00588652995491661,0.00382563684810755,-0.0016117182673742,0.0133847781772074,0.123889812768945
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47548,-0.00695836829305685,0.00848654251347848,-0.0235919916194747,0.00967525503336097,0.412264643406759
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47559,-0.000962954443791541,0.00396348415946972,-0.0087313833963522,0.00680547450876912,0.808041212375685
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47559,0.0139349976490115,0.00717424924337764,-0.000126530868008701,0.0279965261660316,0.0521052819590952
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47648,-0.00162356787081022,0.00377543306776193,-0.00902341668362359,0.00577628094200316,0.667174270425743
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47648,0.00862361663247904,0.00429099245922433,0.00021327141239936,0.0170339618525587,0.0444742843553049
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47648,0.00144288044185406,0.00560189872231091,-0.00953684105387533,0.0124226019375834,0.796741154320939
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47648,-0.0144694584318105,0.00816584693127444,-0.0304745184171084,0.00153560155348738,0.0764162678558195
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47648,-0.00322357739755723,0.00830958152600087,-0.0195103571885189,0.0130632023934045,0.698067705989595
PRAME,Melanoma antigen preferentially expressed in tumors,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47648,-0.0131899479026089,0.0108421986688812,-0.0344406572936161,0.00806076148839838,0.223792380119185
PRAME,Melanoma antigen preferentially expressed in tumors,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37599,-0.000976434498948641,0.00249346469476604,-0.00586362530069009,0.00391075630279281,0.695361994522163
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X864.Number of days or week walked 10+ minutes,47218,-0.00998481530222581,0.0462151162134133,-0.100566443080516,0.0805968124760642,0.828950044296024
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X874.Duration of walks,43798,-0.00301103896399234,0.00193877074795992,-0.00681102962999379,0.000788951702009111,0.120423721412456
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46303,0.00106514491391496,0.0453717091897992,-0.0878634050980914,0.0899936949259214,0.981270820255849
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X894.Duration of moderate activity,41122,-0.0530924259046935,0.0549440681441204,-0.160782799467169,0.0545979476577825,0.333908352124792
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X90087.No-wear time bias adjusted average acceleration,29389,0.00379951313481102,0.00404604322671337,-0.00413073158954718,0.0117297578591692,0.347741338964738
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46322,0.0214364666908652,0.0466028708762221,-0.0699051602265301,0.11277809360826,0.645533946573803
PRAME,Melanoma antigen preferentially expressed in tumors,Physical activities,X914.Duration of vigorous activity,35942,0.000973232948725653,0.00264123099244579,-0.00420357979646809,0.0061500456939194,0.712524358897359
